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CUTTING THE CORD TO PRIVATE CORD
BLOOD BANKING: ENCOURAGING
COMPENSATION FOR PUBLIC CORD
BLOOD DONATIONS AFTER FLYNN V.
HOLDER
SEEMA MOHAPATRA
This Article argues that the Ninth Circuit’s recent
ruling in Flynn v. Holder, which allowed compensation for
peripheral blood stem cells (“PBSCs”) obtained via
apheresis1 under the National Organ Transplant Act
(“NOTA”), also opens up the possibility for compensation for
umbilical cord blood (“cord blood”). The holding in Flynn
applies to cord blood for several reasons. First, Flynn held
that bone marrow was subject to NOTA’s prohibition on
compensation because bone marrow was explicitly
mentioned in the statute. In contrast, no mention of cord
blood appears in NOTA or its applicable regulations. Also,
the procedure to utilize cord blood was not in practice at the
time of NOTA passage and could therefore not have been
contemplated by Congress. Additionally, similar to PBSCs,
when Congress revisited NOTA and passed later
amendments adding fetal organs to the prohibition on
payment, it chose not to modify the statute to explicitly
include cord blood. Finally, there is a longstanding view
that blood should not be covered by NOTA’s prohibitions
 Assistant Professor of Law, Barry University School of Law, Orlando, Florida.
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Society of Law and Medicine Health Law Professors Conference at the Arizona
State University Sandra Day O’Connor College of Law for their helpful insight in
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appreciation to Patrick Burton, Madeline Buczynski, Sarah Beres, and Ariel Niles
for their helpful research assistance, to Heather Kolinsky, Manas Mohapatra, and
Sanjay Reddy for their helpful comments on earlier drafts of this Article, and to
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1. Apheresis refers to the process whereby the whole blood is removed from a
donor, the blood is separated into individual components, the specific portion of
the blood needed is separated and the remaining blood is introduced back into the
bloodstream
of
the
donor.
Melissa
Conrad
Stöppler,
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MEDICINENET.COM, http://www.medicinenet.com/hemapheresis/article.htm; see
also infra notes 44–50 and accompanying text.
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and this should apply equally to cord blood.
Until recently, bone marrow transplants and PBSC
transplants were the only two options for individuals
suffering from diseases that damaged bone marrow, such as
leukemia and lymphoma. However, advances in technology
have allowed cord blood transplants to become a viable
alternative to marrow and PBSC transplants for patients
who have been unsuccessful in finding a PBSC or bone
marrow match. This Article contends that rather than
focusing only on increasing the numbers of bone marrow
and PBSC donors, it is prudent to focus on increasing cord
blood donations as a method of overcoming this problem.
The lack of minority or mixed-race bone marrow, PBSC, and
cord blood donors in the United States is a significant public
health problem that has not been addressed adequately.
Cord blood is taken from the umbilical cord of a
newborn after the cord has been detached from the baby.
Cord blood can be used to treat more than seventy diseases.
Expectant mothers are not well-informed about the option to
donate cord blood. Often, a pregnant woman’s sole source of
information about cord blood is from marketing materials
provided by private cord blood banks. These private banks
offer to store a baby’s cord blood for a hefty yearly fee, selling
this service as a sort of life insurance policy that could be
cashed in should the child get sick in the future. The
American Academy of Pediatrics and the American College
of Obstetrics and Gynecology advise against private cord
blood banking because stored cord blood is of very little
value to the individual from whom it was retrieved. In
contrast, cord blood that is donated to a public bank can be
very useful to individuals requiring a bone marrow
transplant. Additionally, recipients of cord blood
transplants are able to withstand an imperfect match
compared to recipients of bone marrow or PBSC transplants.
This is significant because it is difficult to find exact
matches for racial minorities and mixed race individuals.
Currently, almost 97 percent of cord blood is discarded as
medical waste. In addition to compensation, this Article also
suggests other methods of making public cord blood
donation a more common practice.
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INTRODUCTION
Devan Tatlow was twenty months old when he was
diagnosed with a rare form of leukemia.2 The disease had
initially responded to chemotherapy and Devan went into
remission.3 Unfortunately in 2010, when he was four years old,
the disease returned and Devan needed a bone marrow
transplant.4 Devan’s parents launched a desperate campaign to
find a suitable bone marrow match for their son.5 A match can
occur only if a bone marrow donor has a very high genetic
similarity to a recipient.6 Because Devan is a multiracial
child—his father is Irish and his mother half Polish and half
South Asian—it was very difficult to find an appropriate bone
marrow match.7 Only 3 percent of potential bone marrow
donors in the National Marrow Donor Program’s8 “Be the
Match” registry (“NMDP”) of eight million donors are
multiracial.9 After an extensive international search and
2. Jonathon LaPook & Phil Hirschkorn, Leukemia Patient—at 4—Highlights
Marrow Need, CBS NEWS (May 30, 2010, 7:35 AM), http://www.cbsnews.com/
2100-18563_162-6531012.html.
3. Id.
4. Id.
5. Jonathon LaPook, M.D., Umbilical Cord Blood: Save It and Save Lives,
CBS NEWS (June 18, 2010, 1:39 PM), http://www.cbsnews.com/2100-503823_1626591788.html.
6. Id.
7. LaPook & Hirschkorn, supra note 2; see also Tanya Snyder, Boy, 4,
Desperately Needs Bone Marrow Transplant, WTOP (May, 17, 2010, 10:01 PM),
http://www.wtop.com/109/1958736/Boy-4-desperately-needs-bone-marrowtransplant.
8. Although still referred to as the National Marrow Donor Program
(NMDP), 42 U.S.C. §274l-1(2) (2006) replaced the National Bone Marrow Donor
Registry with the C.W. Bill Young Cell Transplantation Program in an effort to
increase transplants. 42 U.S.C. §274k (2006). The largest donor registry in the
United States is the NMDP. Noel Barnard, Throw Me a Bone Marrow Transplant:
Peripheral Blood Stem Cells and the National Organ Transplant Act, 13 N.C. J. L.
& TECH. 387, 392 (citing AM. CANCER SOC’Y, STEM CELL TRANSPLANTS
(PERIPHERAL BLOOD, BONE MARROW, AND CORD BLOOD TRANSPLANTS) 10 (2011)).
NMDP’s Be The Match Registry (“Registry”) contains 16.5 million donors and
adds approximately 54,000 donors every month. NAT’L MARROW DONOR PROGRAM
& BE THE MATCH, KEY MESSAGE, FACTS & FIGURES 1 (2012), available at
http://marrow.org/workarea/DownloadAsset.aspx?id=1071. There is a dearth of
minority donors in the Registry. The Registry contains almost seven million
potential white donors, but only about 685,000 African-American donors.
Barnard, supra. A white person has a 93 percent chance of finding a donor
through the NMDP, while Blacks have only a 66 percent of finding a donor. NAT’L
MARROW DONOR PROGRAM & BE THE MATCH, supra.
9. Sandra G. Boodman, Multiracial Patients Struggle to Find Donors for
Bone Marrow Transplants, WASH. POST (June 1, 2010), http://www.
washingtonpost.com/wp-dyn/content/article/2010/05/31/AR2010053102481.html.

2013]

CUTTING THE CORD

937

recruitment campaign to attempt to recruit more multiracial
donors, Devan’s family was still unable to find a bone marrow
match.10
A decade ago, the lack of such a match would have meant
that Devan’s prospects at survival were dim and the story
would end here. However, in the last several years, cord blood
transplants are increasingly being used to treat diseases that
were previously only treated with bone marrow transplants.11
Thankfully, Devan’s family was able to locate a matching cord
blood unit, and Devan is a healthy little boy due to a successful
cord blood transplant.12
Just as in Devan’s case, cord blood transplants are
increasingly becoming a viable alternative to bone marrow
transplants for those individuals who are unable to find a bone
marrow match.13 Similar to bone marrow, cord blood contains
blood-forming cells that can be used in transplants for patients
with leukemia and lymphoma as well as many other lifethreatening diseases.14 This is particularly significant for those
in minority and mixed-race populations, who are much less
likely to find a bone marrow or PBSC match using the NMDP
registry than whites.15 Bone marrow donors need to have an
even higher genetic similarity to their recipients than cord
blood and organ donors.16 It is not rare for minorities or mixedrace individuals in the United States to die while waiting for a
matching bone marrow donor or stem cell donor.17 Within the
10. Id.
11. Cord Blood is Changing Lives, NAT’L MARROW DONOR PROGRAM,
http://marrow.org/Get_Involved/Donate_Cord_Blood/Cord_Blood_is_Changing_
Lives/Cord_Blood_Is_Changing_Lives_Today.aspx (last visited Nov. 10, 2012).
12. Tanya Snyder, Doctors Find Match for Boy in Need of Transplant, WTOP
(June 18, 2010, 2:14 PM), http://www.wtop.com/?nid=25&sid=1959996.
13. Cord Blood is Changing Lives, supra note 11.
14. Id.
15. Currently, there are only 165,000 umbilical cord blood units on the Be The
Match Registry. Id. There is still a lack of cord blood units from minority and
mixed race patients. Id. “Adding more cord blood units from diverse racial and
ethnic backgrounds to the registry increases the likelihood that all patients will
find a match.” Id.
16. Christopher Shay, Bone Marrow Transplants: When Race Is an Issue,
TIME
MAG.
(June
3,
2010),
http://www.time.com/time/health/article/
0,8599,1993074,00.html.
17. Shawn Doherty, Racial Disparities Found Throughout Organ Transplant
Process, THE CAP TIMES (July 30, 2010, 10:00 AM), http://host.madison.com/ct/
news/local/health_med_fit/article_1175c506-9b4a-11df-828c-001cc4c002e0.html.
Unlike for bone marrow or cord blood, “race is not a direct factor” when seeking an
organ match. Id. It is possible for a person of one race to receive a kidney from a
person of another race. Id. However, the “odds are that people of the same ethnic
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NMDP registry, the vast majority of donors are white.18
Unfortunately, there is a dearth of donors of other races.19
Within the NMDP, white recipients find a willing donor 65
percent of the time, while Latinos find a willing donor only 45
percent of the time, Asian patients only 40 percent of the time,

or racial background are more likely to have compatible blood and tissue types.”
Id. For this reason, race still plays an important role in organ donations as
minorities have a more difficult time than whites in finding matching organ
donors. See Nicolette Young, Note, Altruism or Commercialism? Evaluating the
Federal Ban on Compensation for Bone Marrow Donors, 84 S. CAL. L. REV. 1205,
1212 (2011). For example, in 2010, 108,983 people were on the waiting list for
various organs, and over 25 percent of these people were African-Americans. April
A. Robinson, Double Standards and Hypocrisy in the Altruistic Organ
Procurement Model: Generous Donors But Irrational Negotiators? 32 HAMLINE J.
PUB. L. & POL’Y 37, 42 (2010). With regard to kidneys, “[w]hile only 13 percent of
the country’s population, blacks make up 40 percent of those on dialysis.”
Doherty, supra. Of African-Americans who registered for a kidney transplant
seven years ago, 39 percent are either still waiting or have died. Id. This number
is “nearly twice the proportion of white patients.” Id. The median waiting period
for organs is long and it has increased drastically across the board. Michele
Goodwin, The Body Market: Race Politics & Private Ordering, 49 ARIZ. L. REV.
599, 616 (2007). In 2001 and 2002 the median wait for a kidney was 1,284 days for
whites and 1,842 days for African-Americans. Id. Part of this problem is the
disparity between races in organ donations in general, as there is a reluctance of
minorities to become organ donors. Doherty, supra. For example, “in Wisconsin,
54 percent of drivers have checked the ‘yes’ box for organ donation on their
driver’s licenses.” Id. However, consent rates for African-Americans in Wisconsin
are half that. Id. One of the factors that has been an obstacle to recruiting more
African-American donors is “overcoming a profound distrust of the medical
system.” Id. The number of Hispanic organ donors also shows a disinclination
towards donating an organ. Jim Forsyth, Many Hispanics Hesitant About Organ
Donation, REUTERS (Mar. 28, 2011, 11:23 AM), http://www.reuters.com/
article/2011/03/28/us-tranplants-organs-idUSTRE72R46R20110328. This trend
has been credited by some to religious beliefs. Carmen Radecki Breitkopf,
Attitudes, Beliefs and Behaviors Surrounding Organ Donation Among Hispanic
Women, 14 Current Opinion in Organ Transplantation 191(2009),
http://journals.lww.com/co-transplantation/Fulltext/2009/04000/Attitudes,_beli
efs_and_behaviors_surrounding_organ.17.aspx. In Texas in 2010, 31 percent of
organ donors were Hispanic, while “42 percent of the state’s population is
[Hispanic].” Jim Forsyth, Many Hispanics Hesitant About Organ Donation,
REUTERS
(Mar.
28,
2011,
11:23
AM),
http://www.reuters.com/
article/2011/03/28/us-tranplants-organs-idUSTRE72R46R20110328.
18. NAT’L MARROW DONOR PROGRAM & BE THE MATCH, supra note 8, at 2. On
the national registry, only a small percentage of the 8 million volunteer donors
are people of color. Id. Seventy-three percent are white, 9 percent are Latino, 8
percent are African-American, 7 percent are Asian/Pacific Islanders, 3 percent are
multi-racial, and 1 percent are Native American. Laura Landro, Building
Diversity in Bone-Marrow Registries, WALL ST. J., May 27, 2009,
http://online.wsj.com/article/SB124338408532856679.html.
19. Young, supra note 17, at 1212 (stating that the proportion of minority
bone marrow donors on the National Bone Marrow registry does not equal their
population percentage).
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and African-Americans only 34 percent of the time.20 Finding a
bone marrow donor for a person of mixed race is “more difficult,
and often impossible.”21 Cord blood is easier to match than
bone marrow and requires less genetic similarity.22 Although
there is still a racial and ethnic component to cord blood,
increasing cord blood donations will help minorities and mixed
race individuals who are unable to find a bone marrow or
PBSC match.23
This Article proposes that the recent Ninth Circuit Court
of Appeals (“Ninth Circuit”) decision, Flynn v. Holder,24 which
held that payments for PBSC obtained via apheresis are
allowed, would allow payment for cord blood as well. This
Article argues that compensating umbilical cord blood donors
could be an effective way to close the gap for minorities and
mixed-race individuals who are in need of bone marrow
transplants, without facing any of the potential ethical
landmines that may arise in compensating bone marrow
donors.
Part I of this Article discusses the value of cord blood for
patients who need bone marrow transplants, particularly
minority and mixed race patients. Part I also describes the lack
20. Id.
21. Id. A recent example of a mixed race individual that died due to the lack
of bone marrow donors is Shannon Tavarez. See Bruce Weber, Shannon Tavarez,
Nala in ‘Lion King,’ Dies at 11, N.Y. TIMES, Nov. 3, 2010, http://www.nytimes.
com/2010/11/03/theater/03tavarez.html. Tavarez was diagnosed with acute
myelogenous leukemia, an aggressive blood cancer requiring a bone marrow
transplant, seven months into her role as Nala on the Broadway show, “The Lion
King.” Id. Like many mixed race individuals needing bone marrow transplants,
Shannon, whose father was Latino and mother was black, was unable to find a
suitable bone marrow match. Juliana Barbassa, Mixed-Race Patients Struggle to
Find Marrow Donors, PHYSORG.COM (May 27, 2009), available at
http://www.physorg.com/news162659550.htm.She was able to extend her life,
however, by finding a match from donated umbilical cord blood and having a cord
blood transplant. See Bruce Weber, Shannon Tavarez, Nala in ‘Lion King,’ Dies at
11, N.Y. TIMES, Nov. 3, 2010, http://www.nytimes.com/2010/11/03/theate
r/03tavarez.html. Unfortunately, the umbilical cord blood transplant was not
successful and Shannon died in 2010 when she was only eleven years old. Id.
22. HLA Matching: Finding the Best Donor or Cord Blood Unit, NAT’L
MARROW DONOR PROGRAM, http://marrow.org/Patient/Transplant_Process/
Search_Process/HLA_Matching__Finding_the_Best_Donor_or_Cord_Blood_Unit.a
spx#hla (last visited Nov. 10, 2012).
23. Id. “Human leukocyte antigen (HLA) typing is used to match patients and
donors for bone marrow transplants or cord blood transplants.” Id. Some racial
and ethnic groups have HLA types that are less common. Id. Therefore, for both
bone marrow and cord blood, the best chance of finding a suitable donor is with
someone of a similar racial or ethnic background. Id.
24. 684 F.3d 852, 865 (9th Cir. 2012).
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of public cord blood donations due in part to the proliferation of
private cord blood banks. Part II discusses NOTA and the
reasons for the ban on compensation for certain organs and
bodily materials under NOTA. Part III examines other
biological material for which compensation is allowed under
NOTA—such as blood, sperm, and eggs—and examines the
historical basis for these distinctions. Part IV discusses the
Flynn decision and the arguments that both parties put forth
regarding whether bone marrow and PBSC donors should be
compensated under NOTA. Part V addresses the criticisms of
the Flynn decision regarding allowing payment for certain
types of PBSC extractions. Finally, Part VI argues that under
Flynn and NOTA, cord blood is a biological material for which
compensation is or should be allowed. Part VI also proposes
ways that the compensation system for cord blood could be
structured to create a robust public cord blood donation system
in the United States instead of the current system, which is
dominated by private cord blood banks and reserves donations
for those who can afford to preserve their own cord blood,
rather than for those who need it most. This Article concludes
that utilizing a combination of policies, including compensation
for cord blood, would increase the number of pregnant women
who donate their cord blood to a public bank and make a
significant public health impact by helping minorities and
mixed-race individuals who need bone marrow and stem cell
transplants have a greater chance of finding a match.
I.

WHY CORD BLOOD TRANSPLANTS ARE IMPORTANT
A.

The Science Behind Cord Blood Transplants

The advent of cord blood transplantation as a viable
alternative to bone marrow transplantation has given hope to
patients who have been unsuccessful in finding a PBSC or bone
marrow match. Patients whose bone marrow has been
destroyed by disease need to replace their damaged bone
marrow cells.25 There are three ways to replace bone marrow in
a diseased individual: bone marrow, PBSC transplants, or cord
blood transplants.26 Each of these methods is explained in turn
25. THE AM. CANCER SOC’Y, STEM CELL TRANSPLANT (PERIPHERAL BLOOD,
BONE MARROW, AND CORD BLOOD TRANSPLANTS) 1 (Nov. 1, 2012),
http://www.cancer.org/acs/groups/cid/documents/webcontent/003215-pdf.pdf.
26. Id. Although commonly referred to as bone marrow transplants, the most
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below.
1.

Bone Marrow and PBSC Transplants

To understand the arguments presented in this Article, it
is important to understand the science behind bone marrow
transplants and PBSC transplants. Bone marrow refers to the
spongy tissue, located inside the hollow part of certain bones,27
which forms red and white blood cells and platelets.28 It
contains hematopoietic stem cells that can develop into any
type of blood cell.29 When a person suffers from a disease that
destroys his or her bone marrow, such as leukemia or
lymphoma, he or she often needs a bone marrow transplant.30
Marrow cells and PBSCs carry a marker called the human
leukocyte antigen (“HLA”).31 HLA proteins, located in a
person’s cells, determine that person’s tissue “type.”32 HLA
markers allow one’s body to recognize foreign cells.33 This
immune response can be deadly when a person receives a
necessary bone marrow or cord blood transplant.34 In order to
reduce this adverse immune response, transplant patients are
matched with donors having a tissue type that is as similar as
possible to that of the recipient.35 HLA tissue types are
common transplants to replace bone marrow are peripheral stem cell transplants.
Id. at 6. In these transplants, peripheral stem cells are extracted from a donor via
apheresis. Id. at 11. In rare circumstances, actual bone marrow is transplanted.
Id. at 8. Bone marrow is retrieved via the aspiration technique. Fact Sheet, Bone
Marrow Transplantation and Peripheral Blood Stem Cell Transplantation, NAT’L
CANCER INST. (Sept. 24, 2010), http://www.cancer.gov/cancertopics/factsheet/Th
erapy/bone-marrow-transplant.
27. THE LEUKEMIA & LYMPHOMA SOC’Y, BLOOD AND MARROW STEM CELL
TRANSPLANTATION 38 (2010), http://www.lls.org/content/nationalcontent/resourcec
enter/freeeducationmaterials/treatments/pdf/bloodmarrowstemcelltransplantation
.pdf.
28. BE THE MATCH, YOUR INTRODUCTION TO MARROW AND CORD BLOOD
TRANSPLANT
7
(2011),
http://marrow.org/Patient/Support_and_Resources/
Resource_Library/Learn_resources/An_Introduction_to_Marrow_and_Cord_Blood
_Transplant_(PDF).aspx.
29. Fact Sheet, Bone Marrow Transplantation and Peripheral Blood Stem Cell
Transplantation, supra note 26.
30. Id.
31. THE LEUKEMIA & LYMPHOMA SOC’Y, supra note 27, at 43.
32. Id.
33. BE THE MATCH, supra note 28, at 8.
34. HLA Matching: Finding the Best Donor or Cord Blood Unit, supra note 22.
35. Id. at 8. Cord blood is now being used as an alternative to peripheral stem
cell or bone marrow transplants. AM. ACAD. OF PEDIATRICS, Cord Blood Banking
for Potential Future Transplantation, 119 PEDIATRICS 165, 165 (2007), available
at http://pediatrics.aappublications.org/content/119/1/165.full.pdf+html. In comp-
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genetically inherited, which is why the most successful
matches are usually from one’s own family members36—
siblings have a 25 percent chance of having the same HLA
tissue type.37 Therefore, the instances of HLA identity between
unrelated patients and donors are relatively few in number.
Patients who are from ethnic minority groups or are of mixedrace backgrounds have an even poorer chance of finding a full
HLA match with an unrelated adult donor due to genetic
heterogeneity and the fact that most marrow donors are
white.38
Once a matching donor is identified, bone marrow can be
transplanted in one of two ways: aspiration or stem cell
apheresis.39 Bone marrow transplants used to be performed
only through aspiration.40 Aspiration is a surgical procedure
where a special hollow needle is inserted into the pelvic bone to
extract the marrow.41 The donor’s body typically replenishes
the lost bone marrow within four to six weeks.42
PBSC apheresis was developed three decades ago and is
now the most common method of bone marrow
transplantation.43 The bloodstream contains hematopoietic
stem cells that migrate from the bone marrow.44 These cells are
collected in a manner similar to that used for collecting blood
donations, but after collection the donor’s blood is run through
arison to bone marrow, the risk of graft-versus-host disease is diminished
compared with similarly mismatched stem cells from the peripheral blood or bone
marrow of a related or unrelated donor. Id. Cord blood is also a useful option
when a patient’s cells do not match an adult donor closely enough. Id. at 166.
“Biologically, a greater degree of human leukocyte antigen mismatch is tolerated
by the recipient and the incidence of acute graft-versus-host reaction is decreased
when umbilical cord blood is used.” THE AM. COLL. OF OBSTETRICIANS &
GYNECOLOGISTS, ACOG COMMITTEE OPINION NO. 399, UMBILICAL CORD BLOOD
BANKING 1 (Feb. 2008), available at http://www.acog.org/~/media/Committee%
20Opinions/Committee%20on%20Obstetric%20Practice/co399.pdf?dmc=1&ts=201
20722T1521237632. Studies show that cord blood does not need to match as
closely as bone marrow. Id.
36. BE THE MATCH, supra note 28, at 8.
37. See Barnard, supra note 8.
38. AM. ACAD. OF PEDIATRICS, supra note 35, at 166. The plaintiffs in Flynn
sought to compensate bone marrow and peripheral stem cell donors to increase
the number of donors for these individuals. Flynn v. Holder, 684 F.3d 852, 855
(9th Cir. 2012).
39. Barnard, supra note 8, at 393 (citing Fact Sheet, Bone Marrow
Transplantation and Peripheral Blood Stem Cell Transplantation, supra note 26.).
40. Barnard, supra note 8, at 393.
41. Id.
42. Id.
43. Id. at 394.
44. Id.
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an apheresis machine which isolates the PBSCs.45 To ensure a
sufficient number of these cells for transplantation, donors are
given drugs for several days prior to donation.46 The collection
process itself takes a few hours and does not require
hospitalization.47
2.

Cord Blood Transplants

Cord blood is now commonly used as an alternative to bone
marrow transplants or PBSC transplants and can treat more
than seventy different diseases.48 Cord blood is taken from the
umbilical cord and placenta of a newborn baby after the
delivery of the child.49 Like PBSCs, cord blood contains
hematopoietic stem cells that have the potential to be lifesaving for people with some cancers, immune deficiencies,
inherited disorders, and metabolic disorders.50
In addition to being both extremely therapeutic and easy to
collect, cord blood has wide usage because recipients of cord
blood transplants are able to withstand a less perfect type
match than recipients of bone marrow transplants.51 This is
especially significant for racial minorities and mixed race
individuals for whom it is very difficult to find exact bone
marrow matches.52 Just like bone marrow cells, cord blood cells
carry an HLA marker.53 Because cord blood transplants
require less exact matching, even with cord blood
transplantation being in its relative infancy compared with
marrow transplants, racial minorities and mixed race
individuals have had better luck finding cord blood matches
than bone marrow matches.54
45. Id. at 395.
46. Id.
47. Id.
48. Jeannette Moninger, The Cord Blood Controversy: Insurance—or
Reassurance?, PARENTS MAG., http://www.parents.com/pregnancy/my-baby/cordblood-banking/the-cord-blood-controversy/ (last visited Nov. 10, 2012).
49. THE AM. CANCER SOC’Y, supra note 25.
50. THE AM. ACAD. OF PEDIATRICS, supra note 35.
51. Id. at 165–66. Cord blood transplant recipients can withstand human
leukocyte antigen mismatch and suffer much less graft-versus-host reaction than
bone marrow transplant recipients. Id. at 166. Additionally, in comparison to bone
marrow, the risk of graft-versus-host disease is diminished compared with
similarly mismatched stem cells from the peripheral blood or bone marrow of a
related or unrelated donor. Id.
52. Cord Blood is Changing Lives, supra note 11.
53. THE LEUKEMIA & LYMPHOMA SOC’Y, supra note 27, at 43.
54. Reasons to Bank Cord Blood, PARENT’S GUIDE TO CORD BLOOD
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Cord blood transplants are also preferred over bone
marrow or PBSC transplants when a patient does not have a
lot of time due to the progression of his or her disease.55 Cord
blood transplants occur over a three-week period as opposed to
the six weeks it takes if there is a PBSC or bone marrow
match.56
Cord blood contains a low number of stem cells acquired
per unit compared with other sources of stem cells.57 For this
reason, cord blood transplants were often not used in large
adults.58 However, technology has progressed and now
combined units of umbilical cord blood are used, which greatly
increases the potential for cord blood transplants in a wider
variety of patients.59
B.

The Process of Cord Blood Donation

In order to donate cord blood to most public banks, the
expectant mother must be pregnant with a single baby, be at
least eighteen years of age, and have no reason to expect
delivery earlier than thirty-five weeks gestation.60 The
procedure to collect cord blood from the delivered placenta does
not interfere with labor and delivery,61 and there are no risks

FOUNDATION, http://parentsguidecordblood.org/reasons.php (last modified May
30, 2012). Bone marrow should be “matched at least for the HLA-A, -B, -C and DRB1 alleles. Since there are usually two alleles for each, in a perfect match, the
donor will have the same eight alleles as the patient, an 8/8 match. A perfect
match is most likely to occur among family members.” Cord Blood Q & A: Why Do
We Need to Have Cord Blood Donated to Public Cord Blood Banks?, NAT’L CORD
BLOOD PROGRAM, http://www.nationalcordbloodprogram.org/qa/why_do_we_need_
it.html (last visited Nov. 10, 2012). In contrast, successful matches for cord blood
have been 5/6 or 4/6 matches for HLA-A, -B and -DRB1 antigens. Id. Thus,
patients who do not have a bone marrow match may have an easier time finding a
cord blood match for transplant.
55. Cord Blood Stem Cells Help Meet Minority Marrow Needs, STEM CELL
INST., (Mar. 1, 2010), http://www.cellmedicine.com/cord-blood-stem-cells-helpmeet-minority-marrow-needs/.
56. Id.
57. THE AM. COLL. OF OBSTETRICIANS & GYNECOLOGISTS, supra note 35, at 1.
58. Id.
59. Id.
60. The Arizona Public Cord Blood Banking Program—Frequently Asked
Questions, ARIZ. DEP’T OF HEALTH SERVS., http://azdhs.gov/biomedical/aztransnet/
documents/ArizonaPublicCordBloodBankingProgram.pdf (last visited Feb. 20,
2013).
61. Eligibility Guidelines for Collecting Cord Blood Stem Cells, CORD BLOOD
BANKING (Aug. 10, 2011), http://www.cordbloodbanking.com/tag/collecting-cordblood/.
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to the mother or child when donating.62 After a baby is born,
the umbilical cord is clamped.63 To extract cord blood, a needle
with a bag attached is inserted into the portion of the cord that
is no longer attached to the baby.64 After this, the bag is sealed,
and the placenta is then delivered.65 Cord blood cannot be used
in certain limited circumstances, such as when the blood
carries infection, in cases of premature birth, birth of multiple
babies, or emergencies during labor and delivery.66
After the cord blood is collected, the blood is placed in a
tamper-proof,
temperature-monitored
container
for
transportation via land or air to the cord blood bank.67 At the
cord blood bank, the personnel then check the integrity of the
cord blood donation and the accompanying paperwork.68 The
blood is then weighed and tested for extreme temperature
changes since it was harvested.69 The cord blood bank next
separates the stem cells from the cord blood, tests the stem
cells for potency, infectious diseases, and viability, identifies
the genetic characteristics of the cells and then freezes and
stores the unit of cells.70 The information is then put into the
database for future matching.71
C.

The Need for More Cord Blood

There is a sheer lack of donated cord blood units. The
NMDP’s “Be the Match Registry” is the largest registry of
potential marrow donors and donated cord blood units in the
world.72 The Registry contains the information of almost 10.5
million potential donors, but only has a mere 185,000 available

62. Cord Blood Donation, NAT’L CORD BLOOD PROGRAM, www.nationalco
rdbloodprogram.org/donation/prospective_donor_faq.html (last visited Nov. 11,
2012).
63. Eligibility Guidelines for Collecting Cord Blood Stem Cells, supra note 61.
64. Id.
65. Cord Blood Banking Frequently Asked Questions, THE AM. COLL. OF
OBSTETRICIANS AND GYNECOLOGISTS (Aug. 2011), http://www.acog.org/~/media
/For%20Patients/faq172.pdf?dmc=1&ts=20120625T1219143933.
66. Id.
67. U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-12-23, NATIONAL CORD BLOOD
INVENTORY: PRACTICES FOR INCREASING AVAILABILITY FOR TRANSPLANTS AND
RELATED CHALLENGES 11 (Oct. 2011).
68. Id.
69. Id.
70. Id.
71. Id.
72. NAT’L MARROW DONOR PROGRAM & BE THE MATCH, supra note 8, at 1.
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cord blood units.73 Given how valuable cord blood is, this
number is much too low, the numbers and percentages
specifically of mixed race and minority donors and cord blood
units are very low. The vast majority of cord blood units—over
one hundred thousand—are from whites.74 There are only
about thirteen thousand black cord blood units, three hundred
Native American cord blood units, eighteen thousand Asian
cord blood units, thirty-four thousand Latino cord blood units,
150 Native Hawaiian cord blood units, and less than seventeen
thousand mixed-race cord blood units.75
The United States Congress, recognizing the need for
genetically diverse and high quality units of cord blood, passed
the Stem Cell Therapeutic and Research Act of 2005.76 The
goal of the Act was to bank an additional 150,000 new cord
blood units.77 Additionally, the Secretary of the Department of
Health and Human Services (“HHS”) established the National
Cord Blood Inventory (“NCBI”), a program that supports public
cord blood banking for use in transplants.78 One of the main
goals of the NCBI is to increase the genetic diversity of cord
73. Id. at 3.
74. Id. at 2.
75. Id.
76. U.S. GOV’T ACCOUNTABILITY OFFICE, supra note 67, at 1; see also Stem
Cell Therapeutic and Research Act of 2005, Pub. L. No. 109–129, 119 Stat. 2550
(codified as amended in 42 U.S.C. § 274(k)–(m)).
77. U.S. GOV’T ACCOUNTABILITY OFFICE, supra note 67, at 1. The Stem Cell
Act authorized the appropriation of $60 million in federal funds through 2010 in
order to make more units of cord blood available for transplantation. Id.
78. Id. at 2. The Food and Drug Administration (“FDA”) also regulates cord
blood banks. The FDA requires that cord blood banks register with the FDA and
comply with current manufacturing, tissue handling, and storage practices and
screen potential donors for certain diseases. Id. at 14. Additionally, now, all cord
blood units must be approved by the FDA. Id. at 15. The Stem Cell Act created an
Advisory Council to assist and advise the Secretary of Health and Human
Services and Administrator of Health Resources and Services on how to perform
the activities related to managing the National Cord Blood Inventory. Id. at 14.
The Advisory Council consists of twenty-five members such as cord blood and
bone marrow donor centers, recipients of transplants, transplant centers, and
banks that partake in workgroups to develop and present recommendations on
how the National Cord Blood Inventory should operate. Id. The GAO report
contained recommendations from banks that adding more staff at collection sites
during more hours of the day or more days of the week, providing recognition or
feedback to motivate medical staff about cord blood collections, and lowering the
age of consent for donating cord blood could all increase collections. Id. at 16. The
GAO report acknowledges that competition from private banks and limited
resources make increasing collections at existing sites more difficult. Id. Another
suggestion in the GAO report to increase cord blood collections was to expand the
number of collections sites. Id. at 17. These efforts could be focused on hospitals
with a high number of minority births. Id.
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blood units available to help ethnic and racial groups find
matches for transplants.79 In 2010, the Stem Cell Therapeutic
and Research Reauthorization Act of 2010 authorized more
funding to increase and support the growth of cord blood
donations to public banks.80
The Government Accountability Office recently submitted
a Report to Congressional Committees on the NCBI.81 In the
National Cord Blood Inventory, 1 percent of the cord blood
units are from American Indian/Alaskan Natives donors, 10
percent from Asian donors, 10 percent from black/African
American donors, 13 percent from Latino donors, and 59
percent from white donors.82 Clearly, there remains a
substantial lack of minority cord blood donors in the United
States.83 More than 40 percent of minority patients suffering
from a bone marrow disease requiring transplantation use cord
blood transplants.84 If the number of cord blood donations from
79. Id. at 2. In order to meet these goals, the Health Resources and Services
Administration entered into thirteen contracts with cord blood banks. Id. By May
31, 2011, the banks had been reimbursed $45.7 million for over 41,000 units of
cord blood. Id. Under the practices used to increase racial and ethnically diverse
cord blood donations, a new pilot program for remote collection of cord blood may
help increase the opportunities to donors in locations where access to public banks
is difficult. Id. at 11–12. According to the GAO report, the remote collections could
not be added to the National Cord Blood Inventory because of FDA licensure
requirements. Id. at 12. If the remote collection can be adjusted to meet the
requirements of NCBI and FDA, this program could increase the number of cord
units from sites around the country that do not have access or opportunity to do so
now, which would likely increase the number of cord blood units from racial and
ethnically diverse groups. Another practice used to increase racial and ethnically
diverse cord blood donations is the awarding of contracts to banks through a
competitive request-for-proposal process. Id. The Stem Cell Act required that the
contract be for ten years and that no funds would be obligated under the contracts
three years after they were entered into. Id. The contract also requires that the
cord blood be available for transplant indefinitely or for as long as it is deemed
viable by Health and Human Services. Id. As part of the competitive process, each
bank puts forward a number of units based on ethnic and racial groups that the
bank will provide to the National Cord Blood Inventory each year. Id. By doing so,
Health Resources and Services Administration use these competitive measures to
increase the diverse minority units available in the Inventory for transplant. Id.
at 12–13. The Health Resources and Services Administration (HRSA) now pays
banks higher rates for minority group units compared to the units collected from
non-Latino Whites. Id. at 13.
80. Id. at 2.
81. Id.
82. Id. at 7.
83. See id.
84. Sara Farris, Mothers Give the Gift of Life Twice with Cord Blood
Donation, UNIV. OF TEX. MD ANDERSON CANCER CTR. (Sept. 19, 2012, 11:08 AM),
http://www2.mdanderson.org/cancerwise/2012/09/mothers-give-the-gift-of-lifetwice-with-cord-blood-donation.html.
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racially and ethnically diverse donors is increased, more
matches can be made for minorities, increasing the likelihood
that those patients will find a match that could save their
lives.85 As discussed later in this Article, the NCBI’s goals
could be achieved if a system of compensation for cord blood
donors is instituted.86
D. The Proliferation of Private Cord Blood Banks and the
Lack of Public Cord Blood Banks: A Public Health
Problem
Although the federal government has been advocating the
establishment of larger and more widespread umbilical cord
blood banks, there currently is not an easily accessible public
cord blood banking option in most areas of the United States.87
Cord blood donations are largely the domain of private cord
banks, and there are currently only twenty-nine public cord
blood banks in the United States.88 Researchers have found
that “the abundance of private cord blood banking options
coupled with the lack of a public cord blood bank alternative in
most areas of the United States prevents the public health
benefits [of cord blood donation], such as improved access to
stem cell transplant for underrepresented minorities, from
being realized.”89
The current scheme of cord blood donation in the United
States is fraught with serious problems. First, pregnant women
85. See Cord Blood Stem Cells Help Meet Minority Marrow Needs, supra note
55.
86. See infra Part VI.B.
87. Anjali J. Kaimal et al., Cost-effectiveness of Private Umbilical Cord Blood
Banking, 114(4) OBSTETRICS & GYNECOLOGY 848, 853 (2009).
88. Find a USA Public Bank, PARENT’S GUIDE TO CORD BLOOD FOUND.,
http://parentsguidecordblood.org/public_usa.php (last modified Oct. 25, 2012). Not
all hospitals work with public banks. Id. For a list of hospitals that participate
and work with cord blood banks, see Participating Hospitals, NAT’L MARROW
DONOR PROGRAM, http://marrow.org/Get_Involved/Donate_Cord_Blood/How_to_
Donate/Participating_Hospitals.aspx (last visited Feb. 8, 2013). “The first public
bank was established at the New York Blood Center in 1991 and other public
banks have since been established in various regions of the country.” THE AM.
COLL. OF OBSTETRICIANS & GYNECOLOGISTS, supra note 35, at 1.
89. Kaimal et al., supra note 87. Even developing countries, such as Mexico,
are beginning to establish public cord blood banks. See Micheal Boo, Public Cord
Blood Banking May Play an Important Role in the Emergence of Unrelated
Transplant in Developing Countries, 48 TRANSFUSION 207, 207 (Feb. 2008),
http://www.imss.gob.mx/salud/BancoSangre/Documents/RolBanco.pdf.
Unfortunately, even in these countries, private cord blood banks are preventing a
robust public cord blood banking system. See Kaimal et al., supra note 87, at 848.
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and prospective fathers are often uneducated about cord blood
donation in general.90 Often, public banking is not even
mentioned to expectant families prior to the birth of their
babies. Although twenty-seven states have passed legislation91
to encourage the discussion of the cord blood banking option,
this appears to benefit the private cord banking industry
instead of encouraging cord blood donation. Although some
states follow the Institute of Medicine guidelines, which
require discussion of all cord blood options, other states simply
require education in general with no specifications.92
Additionally, the majority of public and private hospitals
in the United States do not have a direct connection to a public
bank.93 There are only a limited number of hospitals in the
United States that participate in the NMDP’s cord blood
banking program.94 In addition to these sites, the National
Cord Blood Program also has a limited number of collection
sites, and these are mostly in New York.95 If a woman is not
delivering in any of the NMDP participating hospitals, she has
the option of donating to one of only four public banks that
accept mail-in donations.96 In contrast, representatives from
private cord blood banks establish friendly relationships and
leave promotional materials at obstetricians’ offices.97
90. MARY HAWS ET AL., DEP’T OF MED. LAB. SCI., WEBER STATE UNIV.,
KNOWLEDGE AND PERCEPTIONS OF CORD BLOOD DONATION AMONG PREGNANT
WOMEN 1–2, http://www.weber.edu/WSUImages/DCHPResearch/mls_2011_12_
projects/GRP4_OUR.pdf (last visited March 12, 2013).
91. 27 States Have Cord Blood Education Laws, PARENT’S GUIDE TO CORD
BLOOD FOUND., http://parentsguidecordblood.org/news/12/ (last modified Mar. 28,
2012). These states include: Arizona, Arkansas, California, Colorado, Connecticut,
Florida, Georgia, Illinois, Louisiana, Maryland, Massachusetts, Michigan,
Missouri, New Jersey, New Mexico, New York, North Carolina, North Dakota,
Ohio, Oklahoma, Pennsylvania, Rhode Island, Tennessee, Texas, Virginia,
Washington, and Wisconsin. Id.
92. Id.
93. Public and Private Cord Blood Banks, SAVE THE CORD FOUND.,
http://savethecordfoundation.org/banking_list.php (last visited Mar. 8, 2013).
94. Participating Hospitals, supra note 88.
95. Cord Blood Donation, supra note 62. The NCBP’s collection sites are New
York-Presbyterian Hospital’s Cornell Weill Medical Center; Brooklyn Hospital
Center; Montefiore Medical Center/Albert Einstein College of Medicine of Yeshiva
University Weiler Hospital; Mount Sinai Medical Center; North Shore University
Hospital in Manhasset; Long Island Jewish (LIJ) Medical Center; Inova-Fairfax
Hospital; and MacDonald Hospital for Women. Id.
96. Donating at Other Hospitals, NAT’L MARROW DONOR PROGRAM,
http://marrow.org/Get_Involved/Donate_Cord_Blood/How_to_Donate/Donating_at
_Other_Hospitals.aspx (last visited Feb. 8, 2013).
97. See Sophie Ramsey, Docs Weigh in on Private Cord-Blood Banking,
CONSUMER NEWS (Mar 19, 2009), http://news.consumerreports.org/health/2009/
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Private Cord Blood Banks: The Hype and the Reality

Despite the greater abundance of information on private
cord blood banking over public, the realities of the process do
not match the hype. Private banking is not cost-effective, will
not likely be useful to those who bank the blood, and
professional organizations are opposed to it.
1.

Cord Blood Banking is Not Cost Effective

The private cord banking industry markets cord blood
storage for future use as a sort of insurance policy98—a private
reserve of stem cells that parents can draw upon in the event
that their child develops a bone marrow disease.
An illustrative example of private cord blood bank
advertising to pregnant women is the Cord Blood Registry’s
(“CBR”) website.99 CBR’s slogan is “Healthy Futures Born
Here.”100 The website gives a one-sided narrative of private
banking and gives inspiring real life stories of how private
banking has saved lives.101 There is not one mention of public
banking on the website. CBR private storage for cord blood and
tissue costs a total of $2,895 for the first year, which is made
up of a one-time cord blood and tissue collection/processing fee
of $2,790, a one-time shipping fee of $170, and an annual
storage fee of $260. However, the reality is that private cord
blood banking does not assure a healthy future for a baby.
A recent study by University of California researchers
found that privately storing umbilical cord blood was not costeffective unless the family had a long history of blood
disorders.102 This study found that the odds of privately stored
umbilical cord blood being used for the family in the next
twenty years was very small and not worth the expense of
storing the cord blood privately for most families.103
Researchers estimate that the chance that an individual
03/private-umbilical-cord-blood-banking.html.
98. Moninger, supra note 48.
99. Cord Blood Banking at its Best, CORD BLOOD REGISTRY, http://www.
cordblood.com/en/best-cord-blood-bank (last visited Feb. 8, 2013).
100. Id.
101. See Our Clients, Their Stories, CORD BLOOD REGISTRY, http://www.cord
blood.com/en/benefits-cord-blood/our-clients-their-stories (last visited Feb. 9,
2013).
102. Kaimal et al., supra note 87, at 848.
103. Id. at 853.
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may actually use his or her own cord blood in lieu of receiving
transplantation from another donor is one in five thousand per
individual.104 The cost of collection and storage usually comes
with a hefty price tag. Private cord blood banking is not costeffective because it costs an additional $1,374,246 per life-year
gained.105 Additionally, a survey by the American Society for
Blood and Marrow Transplantation found that only ninety-nine
of the approximately 460,000 cord blood units banked in
private cord blood banks were confirmed as being shipped for
use in treatment.106
2.

Privately Banked Blood Will Likely Never be
Useful to Those Who Banked It

As noted above, the cost-effectiveness of privately banking
cord blood is reduced by the low likelihood that the blood will
actually be useful to those who banked it. Parents who bank
their baby’s cord blood have a less than 0.04 percent chance of
ever being able to use that blood to help their child and an only
slightly higher chance for family members.107
Because of the way cord blood banking is marketed, many
parents who choose to invest in the significant cost of private
banking do so because they believe that if their child develops a
disease, this cord blood will be useful in curing their child’s
disease.108 However, if that child develops a disease such as
leukemia, using their own cord blood will most likely not be an
option as the genetic predisposition to the disease is already in
the cord blood.109 The stored cord blood may only be useful for
other siblings.110 Even members of the American Congress of
Obstetricians and Gynecologist’s (“ACOG”) own ethics
committee have stated that “‘there’s no reason for parents to
take on this additional financial burden when there’s little
chance of a child ever using his own cord blood.’”111 Parents
104. Private Cord Blood Banking: The Basics, BABY CTR., http://www.
babycenter.com/0_private-cord-blood-banking-is-it-for-you_1369773.bc (last updated June 2012).
105. Kaimal et al., supra note 87, at 848.
106. Id.
107. Id.
108. Id.
109. Cord Blood Banking Pros and Cons, M.A.Z.E. CORD BLOOD LABS.,
http://www.mazecordblood.com/private-vs-public.htm (last visited Feb. 8, 2013);
see also Moninger, supra note 48.
110. Cord Blood Banking Pros and Cons, supra note 109.
111. Moninger, supra note 48.
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have recently filed lawsuits after realizing the futility of cord
blood banking when their child has been diagnosed with an
illness caused by a genetic problem.112
3.

Professional Organizations Oppose Private Cord
Blood Banking for Most Individuals

Professional organizations discourage the use of private
cord blood banking. The American Academy of Pediatrics
discourages private cord blood storage and encourages public
cord blood donation.113 In February 2008, ACOG released a
policy about umbilical cord blood banking.114 It encourages
obstetricians to provide a patient who requests information on
umbilical cord blood banking with balanced and accurate
information regarding the advantages and disadvantages of
public versus private banking.115 It advises physicians to
educate pregnant women about the “remote chance of an
autologous unit of umbilical cord blood being used for a child or
a family member (approximately 1 in 2,700 individuals).”116
ACOG further advises that cord blood collection not alter
routine practice for the timing of umbilical cord clamping.117
Finally, ACOG advises that “physicians . . . who recruit
pregnant women and their families for for-profit umbilical cord
blood banking should disclose any financial interests or other
potential conflicts of interest.”118
The American Association of Pediatrics (“AAP”) is
similarly negative about the benefits of private cord blood
112. See, e.g., id. For example, the Dones chose to privately bank their son
Anthony’s cord blood. Id. When Anthony was diagnosed with osteopetrosis, a
potentially fatal disorder that affects bone formation, at four months of age, the
Dones were shocked to discover the cord blood they had stored could not be used
to save Anthony. Id. The cord blood could not be used for transplant because the
cells had the same genetic defect that caused Anthony’s illness. Id. The Dones
have filed a lawsuit against the private cord blood bank claiming false advertising
and consumer fraud. Id. This is based on their claims that they were told in
printed materials given to them by the private cord bank that storing the cord
blood was akin to a life insurance policy that could save Anthony’s life should he
need it in the future. Id. The bank never mentioned the possibility that the cells
that were stored would contain the debilitating disease as well. Id.
113. See AMERICAN ACAD. OF PEDIATRICS, supra note 35, at 167.
114. THE AM. COLL. OF OBSTETRICIANS & GYNECOLOGISTS, supra note 35, at 1.
115. Id. at 2. The policy notes that the benefits of “long-term storage of
autologous umbilical cord blood [have] been questioned.” Id.
116. Id.
117. Id.
118. Id.
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banking.119 AAP warns, “Cord blood-banking recruitment
practices should be developed with an awareness of the
possible emotional vulnerability of pregnant women and their
families and friends. Efforts should be made to minimize the
effect of this vulnerability on cord blood-banking decisions.”120
If cord blood transplants are to remain a viable alternative
to bone marrow and PBSC transplants, collection and banking
procedures will need to be addressed. Although NOTA, which is
discussed in the following sections, specifically addresses organ
transfer and donation, it is silent as to cord blood, leaving
questions about collection and banking open for debate,
especially after the Flynn v. Holder decision.
II. THE NATIONAL ORGAN TRANSPLANT ACT OF 1984 AND THE
POLICY REASONS BEHIND THE BAN ON COMPENSATION FOR
ORGANS
Under NOTA,121 which was enacted in 1984, it is unlawful
for any person to knowingly transfer any human organ for
valuable consideration for use in human transplantation if the
transfer affects interstate commerce.122 NOTA defines “human
organ” as any human kidney, liver, heart, lung, pancreas, bone
marrow, cornea, eye, bone, and skin or any subpart thereof or
any other human organ specified by the Secretary of Health
and Human Services by regulation.123 When the statute speaks
of “valuable consideration”124 it does not include reasonable
119. See AM. ACAD. OF PEDIATRICS, supra note 35, at 166.
120. Id. at 167–68.
121. 42 U.S.C. § 274e (2007).
122. Id. § 274e(a). Some countries do allow compensation for organs.
Compensation for living organ donors is legal in Iran. Lisa M. Derco, Note,
America’s Organ Donation Crisis: How Current Legislation Must be Shaped by
Successes Abroad, 27 J. CONTEMP. HEALTH L. POL’Y 154, 163–64 (2010). This is
done through a state regulated system. Id. at 163. Through this system, donors
receive $1,200 as well as health insurance from the government for their
donation. Id. at 164. Additionally, donors receive compensation from the donee.
Id. If the donee cannot afford to pay this compensation then “several charities
have been established to provide compensation to the donor.” Id. This practice has
led to Iran being the only country in the world that does not have a shortage of
donated organs. Id. at 163; see also Alex Tabarrok, The Meat Market, WALL ST. J.,
Jan. 8, 2010, http://online.wsj.com/article/SB1000142405274870348100457464623
3272990474.html.
123. 42 U.S.C. § 274e(c)(1) (2007).
124. Although live organ donations are not compensated in most countries,
some countries allow for the medical expenses that were incurred during the
transplant to be reimbursed. See Derco, supra note 122; see also Amnon Meranda,
Knesset Approves Organ Donation Law, YNETNEWS.COM (March 25, 2008, 2:00
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payments that are associated with the procedure itself.125
Additionally, payments that are meant to reimburse the donor
for travel expenses and lost wages are allowable.126
The legislative history of NOTA states that “human body
parts should not be viewed as commodities.”127 However, it
does not specifically state the reasons for this view. In Flynn v.
Holder, the Ninth Circuit presented possible policy reasons for
this stance.128 First, the court supposed that Congress might
have been concerned that poor patients could be induced to sell
their organs creating medical risks or pain for poor donors.129
Second, the court theorized that patients needful of transplants
might be threatened by matching donors to give them
exorbitant amounts of money or face death.130 The Ninth
Circuit also suggested that Congress might have thought that
the practice of extracting organs by fraud or force could be
stimulated.131 Finally, the court presented the notion that
Congress may have worried that this practice could “degrade
the quality of the organ supply, by inducing potential donors to
lie about their medical histories in order to make their organs

PM), http://www.ynetnews.com/articles/0,7340,L-3523461,00.html; see also Benny
Moshe & Hana Levi Julian, Organ Donor Compensation Bill Passes Knesset
Committee,
ISRAELI
NAT’L
NEWS
(Jan.
7,
2010,
4:28
PM),
http://www.israelnationalnews.com/News/News.aspx/135415. In the United
States, under 42 U.S.C. § 274e, “valuable consideration” for the selling or
transplanting of organs is prohibited; however, reasonable payments that
reimburse the donor for the medical expenses of the transplant are permitted. See
42 U.S.C. § 274e(a), (c)(2) (2007) (noting that these costs are not prohibited and by
inference would be permitted).
125. 42 U.S.C. § 274e(c)(2). It is important to note that this law does not apply
to human organ paired donation. Id. § 274e(a). Human organ paired donation is
described as when one donor (donor 1) wants to donate a human organ to a
particular patient (patient 1) but the donor is biologically incompatible as a donor
for the patient. Id. § 274e(c)(4)(A). There is also a second donor (donor 2) who
wants to donate a human organ to a different particular patient (patient 2) but is
also biologically incompatible as a donor for the patient. Id. § 274e(c)(4)(B). If
donor 1 is biologically compatible as a donor to patient 2 and donor 2 is a
biologically compatible donor for patient 1, the statute does not apply. Id. §
274e(a).
126. 42 U.S.C. § 274e(a), (c)(2).
127. S. REP. NO. 98-382, at 17 (1984), reprinted in 1984 U.S.C.C.A.N. 3975,
3982.
128. Flynn v. Holder, 684 F.3d 852, 860 (9th Cir. 2012).
129. Id.; see also Jennifer M. Smith, “Dirty Pretty Things” and the Law: Curing
The Organ Shortage & Health Care Crises in America, 12 CHAP. L. REV. 361, 368–
69 (2008) (arguing that the supply of living donors will largely come from the poor
segment of society—a segment that is often exploited).
130. Flynn, 684 F.3d at 860.
131. Id.
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marketable.”132
In addition to these policy arguments, the Ninth Circuit
also presented possible philosophical reasons for the
prohibition on compensation of organ donations133—namely,
that commerce regarding organs “is generally seen as
revolting.”134 The Ninth Circuit attributed this to cultural
taboos.135 With regard to the argument that certain groups will
be exploited if compensation for organ donors were allowed,
some argue that “there is a lack of empirical evidence to
conclusively establish that offering economic incentives will
promote organ donations. Yet, there is clear evidence
demonstrating [that] economic incentives for donating parts of
the human body will lead to exploitation of underprivileged
groups.”136 However, the argument that this compensation
scheme will lead to exploitation of underprivileged groups is
harder to make in the bone marrow context. Supporters of the
ban on compensation ostensibly seek to protect ethnic minority
groups from exploitation; however, these are the very groups
that are the most disadvantaged by the status quo lack of
donors.137
It has further been suggested that if donors were
compensated, this new marketplace would drive out altruistic
donors, thereby decreasing both the supply and quality of
donated organs.138 However, financially motivated and
132. Id.
133. Id. at 861. Some countries, like Israel, have created ways for donors to be
compensated. Meranda, supra note 124. In Israel, a recently enacted law allows
for a person who has made living organ donations of a kidney or part of a liver to
attain the status of “chronic patient.” Id.; see also Moshe & Julian, supra note 124.
This means that the donor does not “have to pay the self-participation fee for any
medical service resulting from the donation.” Meranda, supra note 124.
Furthermore, the donor is compensated approximately $5,100 from the State. Id.
This money is viewed as a “ ‘safety net’ against financial and health damages that
may be caused by the organ donation.” Moshe & Julian, supra note 124. Singapore
now compensates organ donors as well. Cody Corley, Money as a Motivator: The
Cure to Our Nation’s Organ Shortage, 11 HOUS. J. HEALTH L. & POL’Y 93, 112
(2010). The country plans to compensate “as much as US $36,000 to individuals
that are willing to donate their organs.” Id.
134. Flynn, 684 F.3d at 861.
135. Id.
136. Jennifer L. Hurley, Cashing In On the Transplant List: An Argument
Against Offering Valuable Compensation for the Donation of Organs, 4 J. HIGH
TECH. L. 117, 132–33 (2004) (arguing that in the past, blood and plasma donors
have been unemployed, indigent, and substance-addicted).
137. See Young, supra note 17, at 1228–29.
138. Id. at 1228. The demand for bone marrow in a market that outlaws
compensation for donors has led to unorthodox methods of procuring donations. In
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altruistic donors can co-exist.139 Moreover, when looking at the
level of blood donations that existed before and after
compensation was allowed, the total amount of donations
increased.140 Arguably, this shows that even if the number of
altruistic organ donations dropped, the total number of
donations could still rise.141
Another argument that has been presented is that if an
open market were created for organs, then poor people would
2010, the Caitlin Raymond International Registry and UMASS Memorial Health
Ventures Inc. hired models to recruit potential bone marrow donors. Denise
Lavoie, Bone Marrow Donor Recruiting Cases Settled, CBS BOSTON (Feb. 2, 2012,
8:37 PM), http://boston.cbslocal.com/2012/02/02/bone-marrow-donor-recruitingcases-settled/#.Tyv3jt6ferk.email. Wearing high heels and short skirts, these
fashion models attempted to “recruit potential registrants during donor drives at
malls, festivals and sporting ventures.” Id. Afterwards, both entities were accused
of “improperly waiv[ing] copayments and deductible amounts for the testing of
potential donors, g[iving] away free T-shirts and h[olding] free raffles for bigscreen televisions and golf clubs.” Id. These activities led to claims of improper
marketing practices for which these entities paid $770,000 to the states of
Massachusetts and New Hampshire. Id. Although certainly questionable, these
practices were effective. Id. Additionally, Caitlin Raymond International Registry
and UMass Memorial Health Ventures Inc. were charged with inflating the rates
of individual donor tests. Id. While these tests only cost $50 to administer, the
price charged by UMass Memorial ranged from network rates of several hundred
dollars to up to more than $4,000. Id. “[D]onor tests performed by UMass
Memorial increased significantly, from about 7,000 in 2008 to more than 40,000 in
2010.” Id. Remarking on the issue, Douglas Brown, the senior vice president and
general counsel of UMass Memorial Healthcare Inc., said that it was regrettable
that certain “practices may have undermined the public perception of the lifesaving importance of donor recruitment.” Id. However, Brown also stated that
these practices did not cause anyone any harm. Id. Furthermore, Brown also
pointed out that “48 patients received transplants from donors in the past year as
a result of the registry’s past recruitment efforts.” Id.
139. Young, supra note 17, at 1228 (citing DAVID PRICE, LEGAL AND ETHICAL
ASPECTS OF ORGAN TRANSPLANTATION 397 (2000)). In fact, some, like
constitutional scholar Eugene Volokh, argue that allowing payment for organs
may be a type of medical self-defense. Allan J. Jacobs, Is State Power to Protect
Health Compatible with Substantive Due Process Rights?, 20 ANNALS HEALTH L.
113, 119 (2011). Volokh argues that the “common law right of self-defense and
constitutional guarantees of substantive due process should” prevent the
government from regulating “therapeutic modalities in some clinical
circumstances.” Id. Additionally, Volokh has also argued that the Supreme Court
has already recognized medical self-defense in the context of abortion. Eugene
Volokh, Medical Self-Defense, Prohibited Experimental Therapies, and Payment
for Organs, 120 HARV. L. REV. 1813, 1824 (2007). This concept has been described
as an apparent right to defend oneself through the use of medical care. Id.
Although the Supreme Court has only recognized the medical self-defense right in
abortion cases, Volokh has argued that it is logical to extend this right when
people need to medically defend themselves through an organ transplant. Id. at
1826.
140. See Young, supra note 17, at 1235 n.197.
141. Id.
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be denied access to organs.142 This argument has been attacked
with the assertion that “the use of money to acquire organs
from donors and the use of money to allocate organs to waiting
recipients” are two different things.143 Therefore, “financial
incentives can be incorporated readily within the current
system without any alteration in the manner through which
transplantable organs are distributed to patients. The only
difference would be that more organs would become available
for distribution.”144
III.

PAYMENT ALLOWED FOR BLOOD, SPERM, AND EGGS
UNDER NOTA: WHY?

Beginning in the 1910s and lasting until the 1970s “a
significant percentage of the United States’ blood supply was
derived from paid human donors.”145 The first documented
blood transfusion took place in 1818.146 However, the results of
early transfusions were normally unsuccessful.147 It was not
until the discovery of multiple blood groups in the early
twentieth century that transfusions became more reliable,
opening the door to blood donations and blood banks.148 The
revolutionary Blood Transfusion Betterment Association
(“BTBA”) was founded in 1929 in New York149 to provide blood
to New York and the surrounding areas.150 The donors were
compensated per hundred cubic centimeters provided.151
Technological advances and increased knowledge of blood
and blood storage led to the practice of civilians donating blood

142. See Corley, supra note 133, at 105–06 (arguing against this assertion).
143. Id.
144. Id. at 106 (citing T. Randolph Beard & David L. Kaserman, On the Ethics
of Paying Organ Donors: An Economics Perspective, 55 DEPAUL L. REV. 827, 831
(2006)).
145. Julia D. Mahoney, The Market for Human Tissue, 86 VA. L. REV. 163, 171
(2000).
146. Id. at 171 n.23.
147. Id.
148. See generally id.
149. The Charles R. Drew Papers: Becoming “the Father of the Blood Bank,”
1938–1941, NAT’L LIBR. OF MED., http://profiles.nlm.nih.gov/ps/retrieve/
Narrative/BG/p-nid/338 (last visited Nov. 14, 2012) [hereinafter Charles R. Drew
Papers].
150. Blood Transfusion Betterment Association, 6 BULL. OF THE N.Y. ACAD. OF
MED. 682, 682 (1930), available at http://www.ncbi.nlm.nih.gov/pmc/articles/
PMC2096130/.
151. Id. at 684.
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and supplying it to forward medical installations.152 This
program was first used in Spain during the Spanish Civil
War,153 and a similar program was instituted by the United
States at the onset of World War II.154 A relief program called
“Blood for Britain” collected blood in American hospitals and
shipped it to England.155 This program was also intended to
gather the information that would be necessary to implement
“a nationwide blood banking program if the U.S. entered the
war.”156 In addition to the Blood for Britain campaign, in 1940,
the Red Cross began looking for civilian groups to provide blood
to ensure a supply would be available to the armed forces if
there were ever a national emergency.157
Throughout World War II the number of donors depended
“largely upon the ebb and flow of battle.”158 During times of
lower military activity, it was difficult for the program to
obtain an adequate number of donors.159 Although the donors
did not receive any payment for their service, they were given
an emblem and a certificate signifying their donation.160
After World War II, human sperm also began to be seen as
a marketable commodity.161 Much like blood donors, donors of
human sperm were compensated for their donations.162
“[A]lthough artificial insemination and blood transfusions did
not gain immediate public acceptance,” the objections that were
raised by the public centered on the practices themselves,
rather than the compensation of donors.163 However, these
sentiments did not prevail, and criticism of donors of bodily
fluids centered on the commodification of these donations.164
152. See Brigadier General Douglas B. Kendrick, Blood Program in World War
II, U.S. ARMY MED. DEP’T 11, available at http://history.amedd.army.mil/
booksdocs/wwii/blood/DEFAULT.htm (last visited Feb. 12, 2013).
153. Id.
154. Charles R. Drew Papers, supra note 149.
155. Id.
156. Id.
157. Kendrick, supra note 152, at 101.
158. Id. at 119–20.
159. Id. at 119.
160. Id. at 148. Another non-monetary incentive to donate blood was the
concept of “blood-time,” where a number of states created “blood-time” programs
under which inmates that donated blood were able to serve reduced sentences. See
Jamila Jefferson-Jones, The Exchange of Inmate Organs for Liberty: Diminishing
the “Yuck Factor” in the Bioethics Repugnance Debate, 16 J. GENDER RACE &
JUST. 105, 132 (2013).
161. Mahoney, supra note 145, at 171.
162. Id.
163. Id.
164. See Kenneth Baum, Golden Eggs: Towards the Rational Regulation of
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In fact, many of the arguments that are currently used
against the commodification of organs were used against the
commodification of donating blood, sperm, and eggs. In the case
of blood, when commercial blood banks first began paying
people for their blood, there were many opponents who claimed
that this commodification would “repress altruism, increase the
risks of unethical medical practice, and exploit the poor to
provide for the rich.”165
Some argue that paying people for their blood would result
in a decrease in the number of charitable donations.166 In the
book The Gift Relationship, Roger Titmuss argued that by
paying people for their blood, “the altruistic motivations that
lead individuals to donate their blood for free” were
undermined.167 This, he hypothesized, would lead to
“[i]ndividuals who would have otherwise donated their blood
for free [being] persuaded by self-interest to ask for the
compensation they now thought they deserved.”168 Titmuss
claimed that “offering material rewards for blood donations
might backfire and lower donations.”169 However, a 2011 study
involving nearly one hundred thousand individuals and
seventy-two blood drives concluded that “providing material
rewards led to a large and significant increase in the
propensity to donate.”170 Furthermore, this effect increased
when the incentive for donating increased.171
Oocyte Donation, 2001 BYU L. REV. 107, 136 (2001).
165. Corley, supra note 133, at 111 (quoting Gail L. Daubert, Politics, Policies,
and Problems with Organ Transplantation: Government Regulation Needed to
Ration Organs Equitably, 50 ADMIN. L. REV. 459, 481 (1998)).
166. See Baum, supra note 164, at 136–37.
167. Id. at 137.
168. Id.
169. Nicola Lacetera et al., Rewarding Altruism? A Natural Field Experiment
26 (Nat’l Bureau of Econ. Research, Working Paper No. 17636, 2011) (discussing
Titmuss’s arguments on payment for blood donations). But see Baum, supra note
164, at 137 (“Whether or not such a shift would lead to an overall increase or
decrease in donations is arguable and likely depends on the amount of
compensation provided. But Titmuss was concerned with more than just
decreasing numbers of blood donors. He was also concerned with the broader
social implications that such a shift would endorse.”).
170. Lacetera et al., supra note 169, at 2, 26.
171. Id. It has been suggested that this trend also exists with egg donors. Egg
donations are accompanied with a degree of risk not found in blood donations.
Russell Korobkin, Buying and Selling Human Tissues for Stem Cell Research, 49
ARZ. L. REV. 45, 60 (2007). “The procedure is painful, is accompanied by the risk of
bleeding and infection, and carries a small but non-trivial risk of substantial
medical complications.” Id. As such, “there are likely to be far fewer altruistic egg
donors.” Id.
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Additionally, some felt that by offering financial
incentives, the quality of donated blood would suffer.172 This
idea was predicated on the belief that this lure of money would
attract “poor individuals harboring infectious diseases [who]
would have reason not to disclose their medical history.”173 It
was thought that if these individuals donated blood, the
donated blood “could harm or even kill its recipient.”174
However, with modern technology, blood banks have
“extremely accurate screening techniques for the major bloodborne infectious diseases.”175 Similarly, egg donors are
“carefully screened through histories, physicals, . . . and genetic
testing.”176 Regardless of this initial reluctance to embrace the
commodification of blood donors, “commercial blood banks are
now widely accepted as commonplace and viewed as a
necessary tool for . . . hospitals.”177
IV. FLYNN V. HOLDER: OPENING UP THE POSSIBILITY FOR
COMPENSATION FOR CERTAIN TYPES OF BODILY MATERIAL
The Flynn v. Holder178 decision is significant because it is
the first time the Ninth Circuit has interpreted NOTA and
examined whether a particular bodily material falls within its
purview. In Flynn, the District Court dismissed the plaintiffs’
claims that NOTA’s ban on payment for bone marrow and
PBSCs was unconstitutional.179 However, upon appeal, the
Ninth Circuit stated that payment for PBSCs did not violate
NOTA.180 The Flynn court held that NOTA was constitutional,
making this decision through its interpretation of the statute
itself.181 Although some scholars have read Flynn as a narrow
decision that will not lead to creation of markets beyond PBSCs
obtained through apheresis,182 this Article contends that Flynn
opens up the possibility that additional bodily material, such as
172. Baum, supra note 164, at 140.
173. Id.
174. Id.
175. Id.
176. Id.
177. Corley, supra note 133, at 111.
178. 684 F.3d 852 (9th Cir. 2012).
179. Id. at 855.
180. Id. at 865.
181. I. Glenn Cohen, Selling Bone Marrow—Flynn v. Holder, 366 NEW ENG. J.
MED. 296, 296 (2012), available at http://www.nejm.org/doi/pdf/10.1056/
NEJMp1114288.
182. See, e.g., id.
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cord blood, may be exempted from NOTA. This section
discusses the key points that were raised in Flynn. In Part VI,
Flynn’s reasoning is applied to cord blood. The Article
concludes that, based on the reasoning in Flynn, cord blood
payment would be allowed under NOTA.
A.

Plaintiffs’ Arguments

Until recently, NOTA had been interpreted as forbidding
compensation for organs, including bone marrow.183 The Flynn
v. Holder case involved several individuals who challenged this
prohibition on compensation for bone marrow donations as
unconstitutional.184 The plaintiffs included parents of children
who would benefit from bone marrow donations; a physician
who provided bone marrow transplants; a parent of a mixedrace child who struggled to find matching donors; an African
American man who suffered from leukemia; and, most
importantly, MoreMarrowDonors.org (“MMD”), a California
nonprofit corporation that sought to operate a program that
would incentivize bone marrow donations.185
NOTA makes it a crime to compensate the donation of a
“human organ.”186 The plaintiffs in Flynn v. Holder argued that
NOTA should not be applied to bone marrow, as bone marrow
donors suffer no permanent harm, experience “no significant
risk, and [the body] quickly regenerates what is donated.”187
This claim centered on the argument that the application of
NOTA to bone marrow violated the Equal Protection Clause of
the Constitution.188 The plaintiffs argued that because bone
marrow donations can be accomplished through apheresis,
“there is no rational basis for allowing compensation for blood,
sperm, and egg donations while disallowing compensation for
bone marrow donations.”189 Specifically, the plaintiffs sought
declaratory and injunctive relief so that a pilot program called
“MoreMarrowDonors.org” could begin offering financial
183. See 42 U.S.C. § 274e (2007).
184. Flynn, 684 F.3d at 855.
185. Id. at 855–56. All of the plaintiffs were connected to MMD in some
manner. See id. at 858.
186. See 42 U.S.C. § 274e.
187. Flynn, 684 F.3d at 858.
188. Id.
189. Id. “The Equal Protection Clause . . . requires the state to articulate a
rational basis for distinctions that it makes in the law.” Cohen, supra note 181, at
296.
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incentives to minority and mixed-race donors of bone
marrow.190 MMD sought to make bone marrow donation more
attractive by providing compensation to donors.191 MMD was
hoping to offer $3,000 awards in the form of scholarships,
housing allowances, or charitable donations to potential
donors.192
The plaintiffs further argued that all bone marrow donors,
regardless of the method of transplant, should be allowed to
receive compensation.193 They contended that donors should
receive compensation if they donated bone marrow or PBSCs,
regardless of the method used to retrieve the material.194
In attempt to show a violation of the Equal Protection
Clause in the application of NOTA to apheresis bone marrow
donation, the plaintiffs claimed: (1) there is no logical
connection to any rational basis; or (2) the distinction between
blood donations and apheresis bone marrow donation “produces
effects so irrational as to be unconstitutional.”195
The plaintiffs maintained that there was no logical
connection to the argument that Congress may have felt that it
is morally and ethically wrong to sell body parts.196 This is
because there is no rational basis for the arbitrary distinction
that it is “perfectly legal to provide scholarships to donors of
mature blood cells, but makes it a major federal crime to
190. Flynn, 684 F.3d at 858. Such an act would be “considered a federal crime
under NOTA.” 9th Circuit Lifts Ban on Selling Bone Marrow: Flynn v. Holder, 19
No. 8 WESTLAW J. HEALTH L. 8, at 10 (Dec. 29, 2011).
191. Flynn, 684 F.3d at 858.
192. Id.
193. Id. at 859.
194. Id. The plaintiffs also argued in their brief that even though the rational
basis test is deferential to the government there are three circumstances in which
the Supreme Court has held that a statutory classification lacks a rational basis
and therefore violates equal protection. Brief of Appellants at 25, Flynn v. Holder,
684 F.3d 852 (9th Cir. 2012) (No. 10-55643). First, when there is “[n]o logical
connection between a statutory classification and any hypothetical rational basis,”
there is no rational basis. Id. at 26 (citing Zobel v. Williams, 457 U.S. 55, 61–62
(1982)). Secondly, when the effects of the statutory classification “are so
manifestly irrational that no rational legislator could have intended them” the
legislation fails the rational basis test. Id. at 28 (citing Allegheny Pittsburg Coal
Co. v. Cnty. Comm’n, 488 U.S. 336 (1989)). Finally, the plaintiffs argued that
“[t]he Supreme Court also rejects asserted rational bases that are motivated by
illegitimate interests such as raw animus toward a disfavored group.” Id. at 29
(citing City of Cleburne v. Cleburne Living Ctr., 473 U.S. 432 (1985)).
195. Id. at 32. The plaintiffs then argued that the possible bases “that the
district court cited in support of NOTA’s facial validity do not support NOTA as
applied to Appellants’ pilot program for the strategic compensation of marrow-cell
donors.” Id. (emphasis in original).
196. Id. at 32–33.
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provide scholarships to donors of immature blood cells.”197
They further maintained that there was no logical
connection to the argument that Congress could have been
concerned that individuals, particularly the poor, will be
coerced by financial pressure into selling their organs.198 To
advance this argument, the plaintiffs argued that there is no
fear of this financial pressure forcing people to donate bone
marrow since bone marrow is a renewable resource.199
Therefore, donors do not lose anything and are not in the same
position to be harmed as they would be if they were donating a
kidney.200
Finally, the plaintiffs reasoned that the court should not
ignore the change in circumstances from when NOTA was
originally written.201 Essentially, the court should take into
account the fact that Congress could not have been referring to
apheresis when NOTA was written as the procedure did not
exist at that time.202 The plaintiffs urged that the Ninth
Circuit take this change in circumstances into account.203
B.

Defendant’s Response

The Attorney General, as defendant, argued simply “that
the statute plainly classifie[d] ‘bone marrow’ as an organ for
which compensation is prohibited.”204 The defendant also
197. Id. at 33; see also Cancer Patients Win Bone Marrow Legal Fight Against
U.S. Attorney General, INST. FOR JUSTICE (Dec. 1, 2011), http://www.ij.org/bonemarrow-release-12-1-2011-2.
198. Brief of Appellants, supra note 194, at 33–34.
199. Id. at 34. Apheresis only impacts the donor’s blood and is replaceable. Id.
200. Id. The plaintiffs went on to argue that there is no logical connection to
the concern that the rich will be at a substantial advantage for purchasing organs
because the donations the plaintiffs are planning on facilitating are shielded from
market-like transactions. Id. at 34–35. In addition to these and other arguments,
the plaintiffs also contended that their equal protection claim can be bolstered
because NOTA as applied to them creates effects so irrational as to be
unconstitutional. Id. at 32. One of these arguments is directed at the District
Court’s argument that Congress could have been concerned “[t]hat [a]llowing
[f]inancial [i]ncentives [w]ould [c]reate [a] [p]owerful [i]ncentive [f]or [a]
[p]otential [d]onor [t]o [p]rovide [a]n [i]naccurate [m]edical [h]istory.” Id. at 37. In
response to this argument, the plaintiffs argued that if this were to happen, the
recipients of the marrow cells would have the possibility of an infection. Id. at 38.
However, if the recipient does not receive any bone marrow cells, the outcome is
much worse: death. Id.
201. Id. at 40–43.
202. Id.
203. Id.
204. Flynn v. Holder, 684 F.3d 852, 858 (9th Cir. 2012).
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argued that there is a rational basis for distinguishing between
blood donations and blood stem cell apheresis donations.205 The
grounds for this argument were that (1) it is harder to find
matches for bone marrow transplants there will be a greater
chance of exploitative market forces to take hold, and (2) bone
marrow transplants have increased health risks over blood
donations.206
The Attorney General stated in his reply brief that there is
no merit to the plaintiffs’ argument that Congress could not
rationally exclude blood from the scope of NOTA without also
excluding bone marrow.207 In addition, the Attorney General
argued that the apheresis method is more involved than
donating blood.208
C.

The Ninth Circuit’s Decision

Ultimately, the Ninth Circuit held for the plaintiffs,
finding that NOTA did not cover stem cell extraction by
apheresis and thus compensation was allowed.209
The court first struck down the plaintiffs’ challenge of the
constitutionality of the compensation ban on bone marrow via
the aspiration method.210 The court reasoned that because bone
marrow is specifically listed as a “human organ” in NOTA, the
ban applies to it.211
205. Id. at 859.
206. Id. However, the government did not take this argument from assertions
made in the complaint. Id. Instead, the government took this argument from a
patient handout called “Now That You Are a Match,” which was published by the
National Marrow Donor Program. Id. The complaint stated that there was no
significant risk. Id. The Ninth Circuit held that because this case was dismissed
on a 12(b)(6) motion, the complaint controls. Id.
207. Brief for the Appellee at 15, Flynn v. Holder, 684 F.3d 852 (9th Cir. 2012)
(No. 10-55643). This is because “‘mere underinclusiveness is not fatal to the
validity of a law’ under the Fifth Amendment’s guarantee of equal protection.” Id.
(quoting Atonio v. Wards Cove Packing Co., 10 F.3d 1485, 1495 (9th Cir. 1993)
(quoting Nixon v. Adm’r of Gen. Services, 433 U.S. 425, 471 n.33 (1977))).
208. Id. at 17–18. This is because five days of injections are needed before the
procedure and “a not insignificant portion of donors require the insertion of a
central venous line to donate using apheresis, which has its own risks and
requires a local anesthesia.” Id. Therefore, “Congress violated no constitutional
restraint by declining to treat bone narrow [sic] donations in the same manner as
blood donations.” Id. at 20. Finally, the Attorney General argued that Congress
revisited the statute in 2007, long after the apheresis procedure began to be used
and that Congress neglected to change the provision. Id. at 19.
209. Flynn, 684 F.3d at 865.
210. Id. at 859.
211. Id. at 859–60. The Ninth Circuit found it irrelevant for this point that
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The court then addressed the plaintiffs’ “no rational basis”
argument under the Equal Protection Clause by delineating
between two classes of rational basis at issue: (1) policy
concerns and (2) philosophical concerns.212 The Ninth Circuit
held that the policy concerns were obvious as Congress could
have had a legitimate concern to protect poor people from being
induced to sell their organs.213 The court also stated that
Congress could have had philosophical concerns for prohibiting
the compensation of organ donors214—namely, people have an
“instinctive revulsion” at the concept of the removal of flesh
from a human being for use by another and particularly the
“commodification” of such conduct.215
The court further noted that Congress need only show a
rational basis, not a persuasive basis for their distinction, and
Congress had done so.216 Therefore, “the prohibition on
compensation for bone marrow donations by the aspiration
method [did] not violate the Equal Protection Clause.”217
The Ninth Circuit additionally stated that there was no
need to answer any constitutional question relating to the
apheresis method.218 The court found that Congress did not
intend to address the method as NOTA contained no express
prohibition against it, considering that the method did not even
exist when the statute was passed.219
The court then examined the text of NOTA to determine
possible implications about extraction of stem cells by the
apheresis method.220 The statute prohibits compensation not
Congress viewed certain types of regenerable tissue as falling outside the
statutory definition of “human organ.” Id.
212. Id. at 860.
213. Id. The Ninth Circuit noted “that although blood can legally be sold,
certain differences between blood and bone marrow justify the view of Congress
that providing financial incentives would reduce altruistic donation and
undermine voluntary donation.” Cohen, supra note 181, 297.
214. Flynn, 684 F.3d at 861.
215. Id.
216. Id. at 861–62.
217. Id. at 862.
218. Id.
219. Id.
220. Id. The Ninth Circuit did not consider whether the compensation of
donations procured through the apheresis method violated the Equal Protection
Clause of the Constitution. Had they chosen to decide this issue on those grounds,
the Ninth Circuit would need to have decided whether allowing the compensation
for blood donations but not for apheresis donations was rationally related to a
legitimate government purpose. Even though the Ninth Circuit did not decide the
case on these grounds, both the plaintiffs and the Attorney General argued
extensively about whether the NOTA ban on bone marrow donations via
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only for donation of an organ but also any subpart thereof.221
The Ninth Circuit rejected the Attorney General’s argument
that hematopoietic stem cells (which are located in the veins)
should be treated as “bone marrow,” reasoning that once these
stem cells are in the bloodstream, they are a “subpart” of the
blood, not the bone marrow.222 The Ninth Circuit therefore
concluded that the PBSC apheresis method of bone marrow
transplantation is not the transfer of an organ or a subpart
thereof.223 Accordingly, they held that NOTA does not
criminalize the compensation of the donor when this method is
used.224
The Obama administration petitioned the Ninth Circuit for
a rehearing, arguing that the Ninth Circuit ignored the intent
of Congress to shield all organ sales from “market forces.”225 In
apheresis violated the Equal Protection Clause in their respective briefs. See Brief
of Appellants, supra note 194, at 12; Brief for the Appellee, supra note 207, at 11.
In attempting to argue this position, the plaintiffs contended in their brief to the
Ninth Circuit that NOTA as applied to them is unconstitutional. Brief of
Appellants, supra note 194, at 14. The district court dismissed the plaintiffs’ equal
protection claim based on the conclusion that rational basis review permits only
facial challenges of law, rather than as-applied challenges. Id. at 15. The plaintiffs
argued that this was in error as both the Ninth Circuit and the Supreme Court
regularly hear as-applied challenges in the rational-basis context. Id. at 15–16.
The Ninth Circuit apparently did not disagree as they heard the case while
making essentially no mention of as-applied challenges in the opinion.
221. 42 U.S.C. § 274e (2007).
222. Flynn, 684 F.3d at 863.
223. Id. at 865.
224. Id. It has been said that the Ninth Circuit’s decision is “both a win and a
loss for advocates of organ markets.” See Cohen, supra note 181, at 297. The
decision is a win given that “patients can now buy and sell peripheral-blood stem
cells derived through apheresis.” Id. However, the win was achieved through the
Ninth Circuit’s interpretation of NOTA. Id. Congress could always change the
statute, as the Ninth Circuit did not make its ruling based on the plaintiff’s Equal
Protection Clause argument. Id. Because of the narrowness in this holding,
“[n]othing in the Ninth Circuit decision foreshadows the creation of markets in
any other types of organs.” Id.
225. Carol J. Williams, Court Asked to Reconsider Ruling On Bone Marrow
Compensation, L.A. TIMES (Jan. 18, 2012, 4:45 PM), http://latimesblogs.
latimes.com/nationnow/2012/01/bone-marrow-compensation.html;
see
also
Appellee’s Petition for Rehearing & Rehearing En Banc at 10, Flynn v. Holder,
684 F.3d 852 (9th Cir. 2012). Additionally, the appeal stated that the panel erred
when it created a distinction between donations of cells from fatty tissue and
donations of cells from peripheral blood. Appellee’s Petition for Rehearing &
Rehearing En Banc, supra, at 2. The Attorney General argued that because
Congress made no distinction, the panel erred in creating one. Id. at 8–9. The
Attorney General further argued that this error undermines the scheme that
Congress created. Id. at 12. Furthermore, the petition stated that even the
plaintiffs did not claim that the statute is limited to only bone marrow cells
obtained from fatty tissue. Id. at 8. The petition argued that the plaintiffs’ claim
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March 2012, the Ninth Circuit denied the government’s
petition for rehearing and rehearing en banc.226 In that denial,
the Ninth Circuit rejected the government’s argument that
because Congress defined “bone marrow” in another statute to
include cells found in peripheral blood, “bone marrow” should
be given the same meaning in NOTA.227 Because the Attorney
General did not petition the Supreme Court to review Flynn,
the Ninth Circuit’s holding will stand.228
D.

The Aftermath

Although advocates of a market-based system for bone
marrow, organ, or tissue donation were hopeful that Flynn
would open the door to such markets, the decision was more
limited in its holding than those advocates had hoped.229
Although patients can now both buy and sell peripheral blood
stem cells that were derived through apheresis, the Ninth
Circuit came to this conclusion through its interpretation of
NOTA, while still upholding the statute as a whole.230 Because
Congress could always change the statute, Flynn would have
had a more far-reaching impact had the Ninth Circuit struck
down the statute or a portion thereof based on the plaintiffs’

was based on equal protection issues and centered on the argument that
“Congress should have limited the scope of the Transplant Act and that it was
irrational not to do so.” Id. at 8. The government argued that the Ninth Circuit
panel took it upon themselves to evaluate medical policy and medical science and
their interpretation is “directly at odds with Congress’s own evaluation.” Id. at 9.
The petition then stated that “Congress addressed scientific developments in
transplant methods in the 2005 Amendments [to the Transplant Act] and defined
‘bone marrow’ to include ‘the cells found in adult bone marrow and peripheral
blood.’ ” Id. The petition stated that this definition covers the process of apheresis.
Id. at 9.
226. Flynn v. Holder, 665 F.3d 1048 (9th Cir. 2011), amended and superseded
on denial of rehearing by 684 F.3d 852 (9th Cir. 2012).
227. Flynn v. Holder, 684 F.3d at 854.
228. Nicholas J. Diamond, Is It Time to Reconsider the National Organ
Transplant Act?, SCI. PROGRESS (July 16, 2012), http://scienceprogress.
org/2012/07/is-it-time-to-reconsider-the-national-organ-transplant-act/. The Ninth
Circuit is bound by the Flynn decision. The Ninth Circuit is comprised of the
states of Alaska, Arizona, California, Hawaii, Idaho, Montana, Nevada, Oregon,
and Washington and the Guam territory. Map of the Ninth Circuit, U.S. COURTS
FOR THE NINTH CIRCUIT, http://www.ca9.uscourts.gov/content/view.php?pk_
id=0000000135 (last visited Mar. 15, 2013). It is by far the largest Circuit in the
United States. U.S. COURTS FOR THE NINTH CIRCUIT, http://www3.ce9.uscourts.
gov (last visited Mar. 15, 2013).
229. Cohen, supra note 181, 296.
230. Id. at 297.
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equal protection argument.231 Although some scholars argue
that “[n]othing in the Ninth Circuit decision foreshadows the
creation of markets in any other types of organs,”232 Part V of
this Article explores how the Ninth Circuit’s discussion of bone
marrow obtained through apheresis could also be applied to
cord blood. Flynn could reasonably be read as allowing
payment for cord blood, which could have a potentially great
impact on public health.
V.

CRITICISMS OF FUTURE IMPLICATIONS AFTER THE FLYNN
DECISION

Much of the criticism of the Flynn decision mirrors the
arguments made by the Attorney General regarding the policy
behind NOTA’s ban on compensation for organs. That is,
opponents of any market-based system worry about the
commodification and coercion that could occur if individuals
who possessed matching bone marrow types were allowed to
name their price for their much-needed bone marrow.233
However, since Flynn was decided, a new concern has
arisen about allowing compensation for bone marrow in the
United States. This concern is what effect such payment would
have on the international community of bone marrow donors
and registries.234 After the Flynn v. Holder ruling, the nine
states bound by the decision no longer conform to international
donor standards that do not accept bodily material that has
been paid for.235 This is significant because more than half of
the bone marrow transplants in 2011 made possible by NMDP
231. Id.
232. Id.
233. See discussion supra Part II.
234. Michael Boo, The Dangers of Repealing Bone Marrow Compensation
Restrictions, U.S. NEWS & WORLD REPORT (Apr. 19, 2012), http://www.usnews.
com/opinion/articles/2012/04/19/the-dangers-of-repealing-bone-marrowcompensation-restrictions.
235. Id. The World Marrow Donor Association (WMDA) fosters international
collaboration for hematopoietic stem cell transplants worldwide. About WMDA,
Who We Are, WORLD MARROW DONOR ASSOC., http://www.worldmarrow.org/ (last
visited May 24, 2013). The WMDA International Standards for Unrelated
Hematopoietic Stem Cell Donor Registries requires that “donations must be
voluntary.” WMDA International Standards for Unrelated Hematopoietic Stem
Cell Donor Registries, WORLD MARROW DONOR ASSOC. 7 (2012),
http://www.worldmarrow.org/fileadmin/
Committees/STDC/20120101-STDC-WMDA_Standards.pdf.
The
standards
further state that “[d]onors must not be paid for their donation but may be
reimbursed for expenses incurred during the donation process.” Id.
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involved an international donor or international patient.236
Some worry that compensation for bone marrow donation could
have a severe impact on both the United States and
international community if international registries excluded
the United States where PBSC payments were allowed.237
These advocates of an altruistic donor system claim that such a
system is far superior to one motivated by financial incentives
and that interpreting the current federal law to allow
compensation of marrow donors “carries serious risks.”238 By
allowing payment for bone marrow (technically, stem cells)
extracted by apheresis, patients may not be able to use the
worldwide search process that is considered imperative to help
increase access to donors.239
Those who advocate bone marrow markets argue that
international organizations have often followed the United
States’ lead when dealing with novel technological and
scientific issues.240 In fact, the United States has the largest
bone marrow registry in the world.241 Advocates of a marketbased system in bone marrow argue that the United States
should not worry about following others’ leads, but rather be a
pioneer in allowing compensation for bone marrow.242
Additionally, it is unlikely that there will be a significant
change in bone marrow donations just based on the Flynn
decision. In fact, the plaintiffs in Flynn were not seeking any
type of monetary compensation for bone marrow. Rather, as
discussed earlier, MMD was proposing scholarship programs
that would compensate bone marrow donors with a $3,000
scholarship.243

236. Boo, supra note 234.
237. Id.
238. Id.
239. Leading Global Cell Therapy Organizations Support DOJ Appeal of
Ruling on Donor Compensation, NAT’L MARROW DONOR PROGRAM (Feb. 2, 2012),
http://marrow.org/News/News_Releases/2012/Coalition_says_PBSC_donor_compe
nsation_poses_health_risks_to_patients_and_donors.aspx. There is also a concern
that those wishing to sell their bone marrow are “more likely to withhold medical
details and information that could harm patients.” Id. Also, there is a concern
that compensation could deter altruistic donors. Id.
240. See Patty B. Wight, Bone Marrow Transplant Donors Compensation Case,
THE ME. PUB. BROAD. NETWORK (Apr. 24, 2012), http://www.mpbn.net/News/
MPBNNews/tabid/1159/ctl/ViewItem/mid/3762/ItemId/21510/Default.aspx.
241. Id.
242. See id.
243. Id.; Flynn v. Holder, 684 F.3d 852, 858 (9th Cir. 2012).
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VI. A NEW FRONTIER?: COMPENSATION FOR CORD BLOOD
AFTER FLYNN V. HOLDER
The lack of minority or mixed-race bone marrow, PBSC, or
cord blood donors is a significant public health problem in the
United States that has not been addressed adequately. Rather
than just focusing on bone marrow and PBSC donors, it is
prudent to focus on increasing cord blood donations as a
method of overcoming this problem. This Article argues that
the Ninth Circuit’s ruling in Flynn that compensation for
PBSCs is acceptable in some circumstances would also allow
compensation for cord blood. If cord blood compensation is
allowed and structured properly, the health outcomes of those
who are unable to find a bone marrow match or cord blood
match could be significantly improved.
This Section proceeds as follows. Part A analyzes how
Flynn leaves open the possibility that cord blood compensation
is allowed under NOTA. Part B proposes schemes whereby
public cord blood donations could be increased with prudent
compensation schemes.
A.

Reading Between the Lines: Flynn and Cord Blood
Compensation

The holding in Flynn applies to cord blood because (1) cord
blood, unlike bone marrow, is not explicitly mentioned by
statute or by HHS regulation; (2) the procedure to utilize cord
blood was not in practice at time of NOTA passage and could
therefore not have been contemplated by Congress; (3) when
Congress revisited NOTA and passed later amendments, it
chose not to modify the statute to explicitly include cord blood;
and (4) the long-standing view that blood should not be covered
by NOTA’s prohibitions applies equally to cord blood.
As discussed in Part II, NOTA makes it a crime for “any
person to knowingly acquire, receive, or otherwise transfer any
human organ for valuable consideration for use in human
transplantation if the transfer affects interstate commerce.”244
Under NOTA, human organs include “the human . . . kidney,
liver, heart, lung, pancreas, bone marrow, cornea, eye, bone,
and skin . . . and any other human organ . . . specified by the

244.

42 U.S.C. § 274e (2007).
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Secretary of Health and Human Services by regulation.”245 The
Secretary of Health and Human Services specified other
human organs by adding, through regulations, “intestine,
including the esophagus, stomach, small and/or large intestine,
or any portion of the gastrointestinal tract.”246
In Flynn, the Ninth Circuit held that compensation for
PBSCs extracted through apheresis was not prohibited by
NOTA.247 The court found that NOTA was constitutional with
regard to banning compensation for bone marrow extracted via
aspiration because bone marrow was specifically listed as a
“human organ” in NOTA.248 In contrast, neither the umbilical
cord nor umbilical cord blood is mentioned in NOTA.
Further, the Ninth Circuit held that NOTA contained no
prohibition against extraction of PBSCs through apheresis
because this method did not exist when Congress passed
NOTA.249 The Ninth Circuit went on to say that Congress
therefore did not intend to address the apheresis method.250
These findings are equally true about cord blood donation.
NOTA was approved in 1984,251 and the first cord blood
transplant did not occur until October 1988.252 Therefore, using
Flynn’s reasoning, similar to apheresis, Congress could not
have intended to include cord blood in its prohibition on
payment for organs.
When NOTA was amended in 1988253 and 1990, PBSC
retrieval via apheresis and cord blood donations had begun to
take place.254 However, the amendments did not mention
either PBSCs extracted via apheresis nor umbilical cord
blood.255 The Ninth Circuit held in Flynn that because it was
245. Id.
246. 42 C.F.R. § 121.13 (2007).
247. Flynn, 684 F.3d at 865.
248. Id. at 859–60.
249. Id. at 862.
250. Id.; see also supra text accompanying note 220.
251. National Organ Transplant Act, Pub. L. 98-507, 98 Stat. 2339 (1984)
(codified as amended at 42 U.S.C. § 274e (2006)).
252. Hal E. Broxmeyer, Cord Blood Transplantation: A Mini Review
Celebrating the 20th Anniversary of the First Cord Blood Transplant, THE
HEMATOLOGIST, Jan–Feb. 2009, available at http://www.hematology.org/
Publications/Hematologist/2009/2199.aspx.
253. Organ Transplant Amendments Act of 1988, Pub. L. 100–607, Tit. IV, 102
Stat. 3114 (1988) (codified as amended at 42 U.S.C. § 274 (2007)).
254. Martin Körbling & Emil J. Freireich, 25 Years of Peripheral Blood Stem
Cell Transplantation, BLOOD 8, available at http://bloodjournal.hematologyl
ibrary.org/content/early/2011/04/01/blood-2010-12-322214.full.pdf.
255. Organ Transplant Amendment Act Tit. IV, 102 Stat. 3114.
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not specifically mentioned, PBSCs extracted via apheresis were
not covered under NOTA’s prohibitions.256 Although the court
was not asked by the plaintiffs in Flynn to interpret cord blood
under NOTA, based on the court’s own reasoning it seems
likely that the court would have ruled the same way—finding
that it is not covered because it is not mentioned in NOTA or
its amendments.
Additionally, the Organ Transplant Amendments Act of
1988 amended NOTA to add a prohibition on fetal organs but
did not mention umbilical cords or umbilical cord blood.257
NOTA specifies organs and does not mention umbilical cords or
cord blood.258 Although NOTA contains language describing the
‘human organ’ to include “any subpart thereof and any other
human organ (or any subpart thereof, including that derived
from a fetus),”259 the defendant in Flynn unsuccessfully argued
that PBSCs were a “subpart thereof” of bone marrow and
therefore compensation for them should not be allowed.260 The
Ninth Circuit reasoned that this would be too expansive a
definition and would include blood as well, which is not covered
by NOTA.261 Even more than PBSCs, cord blood does not fit
into any of the definitions of any of the organs named in NOTA.
Peripheral stem cells are a subpart of bone marrow, but the
Ninth Circuit rejected this interpretation of NOTA because it
would then also include blood, which is a subpart of each
organ.262 In contrast, cord blood is not a subpart of any organ.
Again, the Ninth Circuit’s reasoning about blood is very
applicable to cord blood. Cord blood is just blood that is derived
from the umbilical cord.263 If blood is exempted from NOTA,
cord blood should be as well.
Some may argue that the umbilical cord is an organ.
NOTA does not define an organ, but it gives examples of
organs, which do not include the umbilical cord. In medical
terminology, an organ is defined as “a differentiated structure
(as a heart or kidney) consisting of cells and tissues and

256. Flynn v. Holder, 684 F.3d 852, 865 (9th Cir. 2012).
257. Organ Transplant Amendments Act of 1988, Pub. L. 100–607, Tit. IV, 102
Stat. 3114 (1988) (codified as amended at 42 U.S.C. § 274 (2007)).
258. 42 U.S.C. § 274e (2007).
259. Id. § 274e(c)(1).
260. Flynn, 684 F.3d at 865.
261. Id.
262. Id. at 863.
263. THE AM. COLL. OF OBSTETRICIANS & GYNECOLOGISTS, supra note 35, at 1.
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performing some specific function in an organism.”264 The
umbilical cord is defined not as an organ but as “a cord arising
from the navel that connects the fetus with the placenta and
contains the two umbilical arteries and the umbilical vein.”265
The umbilical cord seems to be more akin to a blood vessel than
to an organ. Arguably, the umbilical cord could be considered
an organ because it is a differentiated structure that connects
the fetus to the pregnant woman. However, its function ceases
once the newborn is delivered.266 In fact, the cord is clamped
and in 97 percent of cases, the remaining umbilical cord is
discarded.267 At this point, it could be argued that the umbilical
cord is no longer “performing some specific function” in the
human body, and is no longer even a part of the human body,
and thus cannot be considered an organ. Unlike a kidney or
heart that also ceases to perform a specific function once it has
been removed, the umbilical cord cannot resume its prior
functioning even if it could be transplanted to another person,
thus further supporting the argument that it should be not
classified as an organ.
Even if one is not persuaded that the umbilical cord is not
an organ, it is actually not the umbilical cord for which
compensation would be theoretically given. What is valuable is
the cord blood, defined as “blood from the umbilical cord of a
fetus or newborn.”268 In Flynn, the Ninth Circuit rejected the
Attorney General’s argument that hematopoietic stem cells
(which are located in the veins) should be treated as “bone
marrow” because the statute prohibits compensation not only
for donation of an organ but also any subpart thereof.269 The
Ninth Circuit reasoned that if the language of the statute were
permitted to be interpreted this way, then blood would fall
under the category of “human organ” as red and white blood
cells that flow in the veins come from the bone marrow, just as

264. Organ, MERRIAM-WEBSTER, http://www.merriam-webster.com/medical/
organ (last visited Nov. 14, 2012).
265. Umbilical Cord, MERRIAM-WEBSTER, http://www.merriam-webster.com/
medical/umbilical%20cord (last visited Nov. 14, 2012).
266. Dr. Allan Bruckheim, Q. What Happens to the Umbilical Cord Inside a
Mother Once . . ., CHI. TRIB. (Oct. 25, 1994), http://articles.chicagotribune.com/19
94-10-25/news/9410260009_1_umbilical-cord-uterus-placenta.
267. Frequently Asked Questions, SAVE THE CORD FOUND., http://www.
savethecordfoundation.org/what_faq.php (last visited Mar. 7, 2013).
268. Cord Blood, MERRIAM-WEBSTER, http://www.merriam-webster.com/
medical/cord%20blood (last visited Nov. 14, 2012).
269. Flynn v. Holder, 684 F.3d 852, 863 (9th Cir. 2012).
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hematopoietic stem cells do.270 It reasoned that once these stem
cells are in the bloodstream, they are a “subpart” of the blood,
not the bone marrow.271 The Ninth Circuit then stated that
“[t]he word ‘subpart’ refers to the organ from which the
material is taken, not the organ in which it was created.”272 It
reasoned that the PBSC apheresis method of bone marrow
transplantation is not the transfer of an organ or a subpart
thereof.273 Accordingly, the statute does not criminalize the
compensation of the donor when this method is used.274 This
reasoning would apply to cord blood as well. The legislative
history of NOTA notes that the definition of “human organ”
specifically does not include blood.275 This should be read to
include cord blood, as cord blood is merely blood that is located
within the umbilical cord. Since it is arguably more valuable
due to its stem-cell-rich content, that should be even more
reason why it would not be included in NOTA’s prohibitions.
The legislative history of NOTA states that “individuals or
organizations should not profit by the sale of human organs for
transplantation. This is not meant to include blood and blood
derivatives, which can be replenished and whose donation does
not compromise the health of the donor.”276 There may be a
concern that cord blood is not replenishable, unlike PBSCs,
sperm, eggs, or hair. The legislative history of NOTA does note
that these exceptions to NOTA are for replenishable body
parts.277 However, a reasonable interpretation of the “which
can be replenished and whose donation does not compromise
the health of the donor” language is that the concern over
bodily material being replenishable is just to ensure that the
donor is no worse off by having donated that material. Under
NOTA, it appears unacceptable to allow payment for bodily
material that, if donated, would put the donor in a worrisome
270. Id.
271. Id.
272. Id.
273. Id.
274. Id. at 865; see also supra note 224 and accompanying text.
275. H.R. REP. No. 98-1127, at 16 (1984) (Conf. Rep.).
276. S. REP. NO. 98-382, at 16–17 (1984), reprinted in 1984 U.S.C.C.A.N. 3975,
3982.
277. H.R. REP. No. 98-1127, at 16 (1984) (Conf. Rep.) (“The term ‘human organ’
is not intended to include replenishable tissues such as blood or sperm.”); see also
J. Brad Reich & Dawn Swink, You Can’t Put the Genie Back in the Bottle:
Potential Rights and Obligations of Egg Donors in the Cyberprocreation Era, 20
ALB. L.J. SCI. & TECH. 1, 24 (2010) (noting that NOTA does not prohibit payment
for human eggs).
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state of health. The Committee seems concerned that the
health of an individual is not permanently compromised in
some way.278 In essence, this concern presupposes an ongoing
need for similar material from the donor. Obviously, this is not
the case with a discarded umbilical cord.
One argument against compensation being allowable
under NOTA may be that cord blood stem cells are not
regenerated within the body of the donor. The concern seems to
be about making the individual “whole” or the same as they
were before they donated. Therefore, one could argue that this
resembles an organ for which one cannot be compensated
under NOTA. However, cord blood is not retrieved from a baby
directly. There is no need for regeneration, as it is already cut
from the body of the newborn. If anything, there is more of an
argument to allow cord blood compensation than any other
type of blood product because there is no impact on the
donor.279 NOTA’s legislative history suggests that payment was
allowed for hair, blood, eggs, and sperm because the human
body replaces these materials within a certain period of time
and the individual is not any worse off.280 In contrast, organs
for which payment is not allowed, such as kidneys, do not
regenerate. But, cord blood does not even need to be
replenished, taking it one step further away from the
underlying health concerns for organs or replenishable bodily
materials. The reality is that individuals who donate, or even
are paid for their cord blood, do not have their health
compromised in any way.
Further, at the time NOTA was enacted, cord blood
transplants were not standard practice and cord blood uses
were just beginning to be explored.281 Therefore, the language
in the statute or legislative history could not have
contemplated cord blood. In 1984, it is probable that the only
bodily materials that could have been used without
compromising the health of the individual were replenishable
materials, such as blood, sperm, and eggs.282 That, coupled
with the exceptions for blood compensation under NOTA,
makes it more likely that NOTA would be interpreted not to
278. See H.R. REP. No. 98-1127, at 16 (1984) (Conf. Rep.).
279. Frequently Asked Questions, supra note 267 (noting that “donation of the
cord blood does not harm the baby or the mother”).
280. See H.R. REP. No. 98-1127, at 16.
281. See supra notes 251–54 and accompanying text.
282. This author contends.
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cover cord blood.283
Using Flynn’s reasoning with regard to PBSCs extracted
through apheresis, this Article contends that cord blood is more
similar to hair, blood, eggs, sperm, and PBSCs, which are all
exempted from NOTA’s compensation requirements. Therefore,
NOTA would arguably allow compensation for cord blood.
B.

An Easy Answer? Compensating Cord Blood Donors

If compensation for cord blood is permitted under NOTA,
there are still several questions to be answered: How should
donors be compensated? Is compensation alone enough to
address the public health need for cord blood? Is the current
collection and banking process sufficient even with
compensation? The following section of this Article addresses
these and other questions regarding cord blood compensation.
1.

How to Compensate Cord Blood Donors

There are a variety of possible forms that compensation for
cord blood could take. The most obvious model would be to have
existing organizations that advocate for more bone marrow and
PBSC donors, such as MMD, offer financial incentives to
minority and mixed-race cord blood donors. In Flynn, MMD
sought to make bone marrow donation more attractive by
providing compensation to potential bone marrow and PBSC
donors.284 MMD proposed offering $3,000 awards in the form of
scholarships, housing allowances, or charitable donations to
potential donors.285 Flynn allowed MMD to proceed with its
plans to recruit potential donors of PBSC.286 MMD proposed to
offer compensation only to minorities and mixed-race
individuals in the first phase of the program due to the dearth
of donors in these populations.287 MMD could offer similar
compensation to ethnic minority or mixed-race pregnant
women who agree to donate their cord blood to a public bank.
MMD structured its proposed compensation program to allay
concern that compensation would change clinical behavior or be
283. Jennifer Kulynych, Blood as a Biological “Drug”: Scientific, Legal, and
Policy Issues in the Regulation of Placental and Umbilical Cord Stem Cell
Transplantation, 32 U. RICH. L. REV. 407, 439 (1998).
284. Flynn v. Holder, 684 F.3d 852, 858 (9th Cir. 2012).
285. Id.
286. Id.
287. Id.
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subject to manipulation.288 In the case of cord blood, this is not
a concern. Once the cord is cut from the mother, she and her
baby are no longer involved in any potential clinical matching
or anything related to the donation. The cord blood extraction
occurs after delivery, and the cord blood is sent to a public
bank. MMD would not need to be involved in matching donors
and recipients. MMD and similar organizations could facilitate
the public donation process for pregnant women in addition to
providing stipends. To receive compensation, pregnant women
wishing to donate their baby’s cord would need to have the
requisite medical tests and meet the same standards that all
donors to public cord banks must meet.289 Unlike in PSBC or
bone marrow transplants, there are no behavioral questions
that could be manipulated because of the possibility of
compensation because the cord is going to be discarded
anyway.290
Instead of scholarships as proposed by MMD, cord blood
donors could receive a stipend towards their medical expenses
or a savings bond for their child. This may help convince
women to donate their cord blood as it will benefit their child in
the future. This could be a true insurance policy, as opposed to
the fictional insurance policy noted earlier in this Article that
is marketed by private cord blood banks.
It may be worthwhile to create a tax credit for those who
participate in public cord donations. The costs of private cord
blood banking are considered a medical expense which may be
deducted from a family’s salary.291 Currently, there is no such
tax advantage for donating cord blood. Structuring cord blood
donation to public banks as tax credits could serve as an
incentive for expectant mothers to donate their valuable cord
blood.
Whatever the form, compensation could increase interest
in cord blood donation. However, compensation alone will likely
not be the most compelling answer to this public health
288. Id.
289. See NAT’L MARROW DONOR PROGRAM & BE THE MATCH, Learn if You Can
Donate Cord Blood, https://secure.marrow.org/Get_Involved/Donate_Cord_Blood/
How_to_Donate/Learn_if_You_Can_Donate_Cord_Blood.aspx (last visited Mar.
28, 2013) (giving checklist for determining eligibility for public cord blood
donation).
290. See Frequently Asked Questions, supra note 267.
291. John Hewitt, Is Cord Blood Banking Tax Deductible?, ESSORTMENT,
http://www.essortment.com/cord-blood-banking-tax-deductible-51235.html
(last
visited Nov. 14, 2012).
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concern.
2.

Need for a Public Health Education Campaign on
Cord Blood Donation

One of the most effective tools of public health is education.
The public, and especially pregnant women, needs to be made
aware of the scientific benefits of cord blood and the ease of
cord blood donation. The proliferation of private cord blood
banks that encourage private storage has led to those who are
aware of the importance of stem cells to privately bank cord
blood, rather than donate their cord blood to public banks.292
As opposed to the thousands of dollars spent to store cord
blood, donation to a public bank is free.293 If more expectant
mothers, especially those who are carrying mixed-race or
ethnic minority babies, were made aware of the dire shortage of
cord blood units by these groups, they would likely be more apt
to donate.294 Public health education is required so that
pregnant mothers are told that by donating their baby’s cord
blood to a public bank, they may be helping people in need of
potentially life-saving cord blood.295
Despite the lack of a proven scientific basis for private cord
blood banking, private cord blood banking seems to be
flourishing,296 while the growth of a public banking system has
been painstakingly slow.297 Researchers in this area advocate
patient education as “the key to shifting the focus to a public
cord blood banking system.”298 Because private cord blood
banks have a “significant conflict of interest” in providing
balanced scientific data about cord blood banking, obstetricians
should “provide evidence-based information to patients.”299
Pregnant women should be made aware that public cord blood
292. This author contends.
293. Frequently Asked Questions, supra note 267.
294. This author contends.
295. Cord Blood Banking Pros and Cons, supra note 109.
296. Theresa Agovino, Cord Blood Banking Industry Flourishes, NBC NEWS,
(Apr. 12, 2004), http://www.nbcnews.com/id/4702857/ns/health-cloning_and_
stem_cells/t/cord-blood-banking-industry-flourishes/#.URAPvx0727w.
297. See Current State-by-State Banking and Legislation Options, SAVE THE
CORD FOUND., http://savethecordfoundation.org/banking_map.php?state=FL#
statedata (last visited Mar. 28, 2013) (giving links to individual state listings of
public versus private cord blood bank options, which reveal a significantly larger
number of private banking options).
298. Kaimal et al., supra note 87, at 853–54.
299. Id. at 854.
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banking is a better scientific alternative to private cord blood
storage.300
Some pregnant women may be concerned about whether
cord blood donation will harm the baby in any way. Pregnant
women should be made aware that their babies’ cord blood is
extracted with no pain to their babies.301 The cord blood, which
is normally discarded along with the cord, would be a potential
source of life for those sick individuals who are in need of a
stem cell transplant.
One issue that may need to be addressed in a public health
education campaign is the distrust by many African Americans
of the public health system in general302 due to the checkered
history of public health disasters such as the Tuskegee Syphilis
Study,303 forced sterilizations and Norplant,304 and even more
recently, the use of stored blood spots for DNA research.305
Issues of racial distrust must be proactively addressed.
Literature in the form of “Q and As” addressing these issues
may be helpful to quell fears of some that their babies’ cord
blood will be used for purposes other than donation. A
comprehensive
public
health
education
campaign,
acknowledging this distrust and explaining the benefits of cord
blood and of public cord blood banking, would likely increase
donors.
3.

Additional Issues to Be Addressed to Bolster Cord
Blood Donation

Cord blood donation should be encouraged, not made to be
a chore. Given that the Flynn decision seems to allow
compensation for cord blood, this compensation could be used
to incentivize public donations. We would go far in addressing
the lack of minority and mixed-race bone marrow matches by
making it seamless and easy for pregnant women to donate
cord blood. Having pregnant women who are interested in cord
blood donation jump through hoops to do something
worthwhile, painless, and easy helps to explain in part why
300. See AM. ACAD. OF PEDIATRICS, supra note 35, at 166.
301. See Frequently Asked Questions, supra note 367.
302. See Vernellia R. Randall, Slavery, Segregation and Racism: Trusting the
Health Care System Ain’t Always Easy! An African American Perspective on
Bioethics, 15 ST. LOUIS U. PUB. L. REV. 191, 191 (1996).
303. Id. at 197–98.
304. Id. at 223–25.
305. Id. at 215–27.
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cord blood donations to public banks are so rare. This could be
changed if pregnant women were offered modest incentives to
donate their baby’s cord blood. As stated above, this could take
the form of a minimal credit (such as $100 or $200) towards
their medical expenses or a savings bond or scholarship for
their babies to use in the future.
There is a lack of knowledge among expectant women
about cord blood donation.306 Many women and health care
providers are not always aware of the possibility to donate
their cord blood.307 There are no glossy pamphlets in most
obstetricians’ offices or hospitals espousing the benefits of cord
donation to compete with the literature given by the private
cord blood banks.308 In the last several years, twenty-seven
states have passed legislation to encourage physicians to
discuss cord blood donation and banking with pregnant
women.309 However, the reality is that public cord blood banks
do not operate all over the United States, while private cord
banks do.310 Another issue is that the process to donate cord
blood is often complicated.311 It is not the routine practice
currently to expect that most mothers will donate their babies’
cord blood. Unless a woman happens to be delivering in one of
the very few hospitals that is set up for public donations, a
woman who does decide to donate must prepare far in
advance.312 She must request a packet of materials from public
banks and these must be completed before labor and
delivery.313 This complicated and sometimes confusing process
for an expectant mother is an additional hassle that prevents
more women from donating cord blood.314
ACOG should consider making cord blood donation a
standard practice in each delivery. ACOG releases practice
guidelines for each aspect of labor and delivery and has

306. MARY HAWS ET AL., supra note 90, at 1.
307. Id. at 1–2.
308. See Ramsey, supra note 97.
309. 27 States Have Cord Blood Education Laws, supra note 91.
310. See Find a USA Public Bank, supra note 88.
311. See How to Donate Cord Blood, NAT’L MARROW DONOR PROGRAM,
http://marrow.org/Get_Involved/Donate_Cord_Blood/How_to_Donate/How_to_Don
ate.aspx (last visited Mar. 15, 2013).
312. See id.
313. Id.
314. Kenny Goldberg, Women Encouraged To Donate Their Baby’s Cord Blood,
KPBS (Apr. 10, 2012), http://www.kpbs.org/news/2012/apr/10/women-encourageddonate-their-babys-cord-blood/.
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previously considered the issue of cord blood banking.315
However, ACOG should be encouraged to go further. ACOG has
the power and expertise to deem that unless a pregnant woman
decides to opt out of donating her cord blood, the standard
practice will be to presume donation316 and give compensation
to cover the costs of collection. This would have an incredible
effect of vastly increasing the public cord blood supply in the
United States. Rather than the arduous opt-in procedure that
currently exists and dissuades all but the most committed
altruistic cord blood donors, an opt-out policy would increase
the number of cord blood donations. Additionally, this would
not prevent anyone who wishes to privately bank their baby’s
cord blood from doing do. Individuals may still choose to
privately donate instead.
Currently, almost 97 percent of cord blood is discarded as
medical waste.317 Therefore, the routine practice is to discard
the umbilical cord. However, if ACOG advocates a change in
the routine practice, the percentage of donated cord blood
would rise dramatically. The revised routine practice could be
to preserve the cord blood, while still allowing the patient the
choice of public donation or private banking (if, for example,
there is a family member with an illness that could be helped
by cord blood). Because extracting the cord blood from the cut
umbilical cord takes additional time,318 there could be
reimbursement or compensation incentives put into place so
that physicians and nurses would be paid for this extraction.
All of these suggestions would significantly increase the
potential for matching cord blood for ethnic minorities and
mixed-race individuals. By simplifying the process to donate
cord blood and making it the routine practice, the number of
donations would increase, which would increase minority
donations available for transplants.319
315. See Resources & Publications, THE AM. COLL. OF OBSTETRICIANS &
GYNECOLOGISTS, http://www.acog.org/Resources_And_Publications (last visited
Mar. 7, 2013).
316. See generally Fact Sheet, THE AM. COLL. OF OBSTETRICIANS &
GYNECOLOGISTS, http://www.acog.org/~/media/About%20ACOG/ACOGFactSheet.
pdf?dmc=1&ts=20130307T2117021760 (last visited Mar. 7, 2013).
317. JoNel Aleccia, Cord Blood Donation Surges as Hospitals Launch Public
Collection Programs, NBC NEWS (May 2, 2012, 8:17 AM), http://vitals.msnbc.msn.
com/_news/2012/05/02/11490071-cord-blood-donation-surges-as-hospitals-launchpublic-collection-programs?lite.
318. See Private Cord Blood Banking: The Basics, supra note 104.
319. Donating to a Public Cord Blood Bank, SAVE THE CORD FOUND.,
http://www.savethecordfoundation.org/banking_public.php (last visited Feb. 10,
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Existing public health screening models could be modified
to accommodate cord blood donation. For example, unless a
mother decides to proactively opt-out of testing, in every state,
every newborn is subjected to a heel prick so that the baby’s
blood may be screened for a slew of metabolic and other
diseases.320 This opt-out model of newborn screening could be
used to formulate an opt-out model of cord blood donation. As
of now, women and families who wish to donate cord blood
must proactively seek out ways to donate to a public bank.321
CONCLUSION
Although this Article advocates for an increased emphasis
for public banking, it is important to acknowledge the
downsides to donating to a public bank. One of the most
obvious downsides is that once cord blood is donated to a public
bank, public banks own the donated cord blood.322 Thus, that
cord blood may not be available for one’s own family member
should a need arise.323 If a family member or a sibling needs
the cord blood in the future, it will not be readily available.324
Although it is unlikely that one’s own cord blood would be
useful to that individual if he or she suffers from a disease,325
the use of cord blood from one’s immediate family doubles the
chance of a successful transplant.326 Theoretically, minorities
and mixed-race individuals may be more worried about the
lack of stem cell matches and may wish to store their baby’s
cord blood at a private facility for future use.327 However,
2013).
320. Newborn Screening Tests, MEDLINEPLUS, http://www.nlm.nih.gov/
medlineplus/ency/article/007257.htm (last visited Mar. 28, 2013).
321. Frequently Asked Questions, supra note 267. Public cord blood banks
generally do not charge to harvest the cord blood. Id. However, physicians may
choose to charge a collection fee not covered by insurance. Cord Blood Banking
Pros and Cons, supra note 109. Some physicians have waived any collection fee
for public bank donations. Id. However, if cord blood donation becomes more
prevalent, this could change. Harvesting cord blood from the cut cord does take
away time from staff to do other things, and physicians or hospitals could charge
to harvest the cord blood. One of the ways compensation could be used would be to
pay hospitals and physicians a fee to cover the cost of this extra time.
322. Cord Blood Banking Pros and Cons, supra note 109.
323. Id.
324. Id.
325. Id.; Moninger, supra note 48.
326. Cord Blood, WOMEN’S HEALTH OF MANSFIELD PA., http://www.
womenshealthofmansfield.com/cord-blood/ (last visited Feb. 10, 2013).
327. See Cord Blood Banking Pros and Cons, supra note 109.
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currently, there are a very small percentage of minorities who
store their babies’ cord blood.328
This Article does not propose eliminating private banking.
If this concern is worrisome for individuals, they may still
choose to privately bank their babies’ cord blood. This Article
proposes methods, including compensation, to encourage cord
blood banking in general, particularly to the vast majority of
the public that allows their babies’ cord blood to be discarded.
Because Flynn seems to allow payment for cord blood, public
health officials, professional organizations, and nonprofits
should work together to devise compensation schemes that
would increase the public cord blood supply in the United
States.

328.

NAT’L MARROW DONOR PROGRAM & BE THE MATCH, supra note 8, at 2.

